Make qwiz for neet pg high level

I need a bit more detail before building the quiz. Let me ask a few quick questions.
Asking for Preferences

Which subject(s) should the quiz cover? Β· How many questions? Β· What format do you want?

Let's go! Here are the rules:
  • 10 high-level NEET PG questions, mixed subjects
  • I'll post one question at a time with 4 options (A-D)
  • Reply with your answer, and I'll give you the explanation + move to the next question
  • Score tracked throughout

🩺 NEET PG High-Level Quiz

Score: 0/0

Q1 of 10 β€” Pharmacology

A 60-year-old man with chronic kidney disease (GFR 20 mL/min) is prescribed a drug for atrial fibrillation. Which anticoagulant requires the most significant dose reduction in severe renal impairment and is contraindicated when GFR < 15 mL/min?
A. Warfarin B. Dabigatran C. Rivaroxaban D. Apixaban
Reply with A, B, C, or D!

B

βœ… Correct! +1
Score: 1/1
Explanation: Dabigatran is a direct thrombin inhibitor that is 80% renally excreted - the highest renal excretion among all NOACs. It requires dose reduction when GFR is 30-50 mL/min and is contraindicated when GFR < 30 mL/min (some guidelines say < 15 mL/min for AF).
  • Warfarin - hepatically metabolized, no renal dose adjustment needed
  • Rivaroxaban - ~33% renal excretion, use with caution but not as restricted
  • Apixaban - only ~27% renal excretion, actually the safest NOAC in CKD

Q2 of 10 β€” Pathology

A 45-year-old woman presents with progressive dysphagia, glossitis, and angular cheilitis. Her CBC shows a peripheral smear with hypersegmented neutrophils and macro-ovalocytes. Bone marrow biopsy reveals large erythroid precursors with open, lacy chromatin but condensed nuclear chromatin in myeloid cells.
The classic finding described in the erythroid precursors is called:
A. Pelger-Huet anomaly B. Nuclear-cytoplasmic asynchrony (megaloblastic change) C. Dyskeratosis D. Ringed sideroblasts
Reply with A, B, C, or D!

B

βœ… Correct! +1
Score: 2/2
Explanation: This is classic megaloblastic anemia (B12/folate deficiency). The hallmark is nuclear-cytoplasmic asynchrony - the cytoplasm matures normally (hemoglobin synthesis proceeds) but the nucleus lags behind due to impaired DNA synthesis. This gives the erythroid precursors their characteristic "open, lacy" (immature) chromatin despite an otherwise mature cytoplasm.
  • Pelger-Huet - bilobed "pince-nez" neutrophils, seen in MDS or inherited
  • Dyskeratosis - abnormal keratinization, seen in epithelial disorders
  • Ringed sideroblasts - iron-laden mitochondria around nucleus, seen in sideroblastic anemia
The clinical clues: hypersegmented neutrophils (>5 lobes), macro-ovalocytes, glossitis, angular cheilitis = B12/folate deficiency until proven otherwise.

Q3 of 10 β€” Physiology

A mountaineer at high altitude (5000 m) has been acclimatizing for 3 weeks. Which of the following is the correct combination of physiological changes expected at this stage?
A. ↑ RBC mass, ↑ 2,3-BPG, right shift of ODC, ↑ EPO B. ↑ RBC mass, ↓ 2,3-BPG, left shift of ODC, ↓ EPO C. ↓ RBC mass, ↑ 2,3-BPG, right shift of ODC, ↑ EPO D. ↑ RBC mass, ↑ 2,3-BPG, left shift of ODC, ↑ EPO
Reply with A, B, C, or D!

A

βœ… Correct! +1
Score: 3/3
Explanation: After 3 weeks of acclimatization at high altitude, all four changes occur together:
  • ↑ RBC mass - EPO-driven erythropoiesis kicks in after ~48-72 hours; by 3 weeks, RBC mass is significantly elevated
  • ↑ 2,3-BPG - hypoxia stimulates glycolysis, increasing 2,3-bisphosphoglycerate production in RBCs
  • Right shift of ODC - 2,3-BPG binds to deoxyhemoglobin and stabilizes the T (tense/deoxy) state, reducing Oβ‚‚ affinity β†’ facilitates Oβ‚‚ unloading to tissues
  • ↑ EPO - initially very high (peaks at ~24-48 hrs), then comes down but remains elevated during acclimatization
Trap in option D: Left shift would mean increased Oβ‚‚ affinity - that's the acute response (respiratory alkalosis from hyperventilation causes left shift initially). By 3 weeks, the 2,3-BPG effect dominates β†’ right shift.

Q4 of 10 β€” Anatomy

A 35-year-old man sustains a posterior dislocation of the hip. On examination, the limb is held in flexion, adduction, and internal rotation. Which nerve is most commonly injured in this scenario?
A. Femoral nerve B. Obturator nerve C. Sciatic nerve D. Superior gluteal nerve
Reply with A, B, C, or D!

D

❌ Incorrect!
Correct Answer: C - Sciatic nerve
Score: 3/4
Explanation: The sciatic nerve is the most commonly injured nerve in posterior hip dislocation - it occurs in 10-20% of cases.
  • In posterior dislocation, the femoral head is driven posteriorly and superiorly, directly into the path of the sciatic nerve as it exits the greater sciatic foramen below the piriformis
  • The peroneal division of the sciatic nerve is more vulnerable than the tibial division (peroneal fibers are more lateral and tethered)
  • Clinically: foot drop, loss of dorsiflexion, sensory loss over dorsum of foot
Why not the others?
  • Superior gluteal nerve - injured in anterior dislocation or iatrogenically during posterior hip surgery (THA); causes Trendelenburg gait (gluteus medius paralysis)
  • Femoral nerve - injured in anterior hip dislocation
  • Obturator nerve - can be injured in obturator/anterior dislocation, not posterior
Memory aid: Posterior dislocation = Posterior nerve (Sciatic) at risk. Limb posture - flexed, adducted, internally rotated = classic "dashboard injury" appearance.

Q5 of 10 β€” Biochemistry

A newborn presents with jaundice, hemolytic anemia, and cataracts. Urine reducing substances are positive but glucose oxidase test is negative. Enzyme assay confirms the diagnosis.
Which enzyme is deficient?
A. Glucose-6-phosphate dehydrogenase B. Galactose-1-phosphate uridylyltransferase C. Galactokinase D. UDP-glucose-4-epimerase
Reply with A, B, C, or D!

B

βœ… Correct! +1
Score: 4/5
Explanation: This is Classic Galactosemia - deficiency of Galactose-1-phosphate uridylyltransferase (GALT), the most severe form.
Why the clues point here:
  • Jaundice + hemolytic anemia - accumulation of Gal-1-phosphate is toxic to RBCs and liver
  • Cataracts - galactose is converted to galactitol (by aldose reductase) which accumulates in the lens
  • Urine reducing substances positive - galactose is a reducing sugar, detected by Benedict's/Clinitest
  • Glucose oxidase negative - confirms it is NOT glucose (glucose oxidase is specific for glucose)
Distinguishing the galactosemias:
EnzymeFeatures
Galactokinase (Option C)Only cataracts - mildest form, no liver/brain involvement
GALT (Option B)Full triad: jaundice + hemolysis + cataracts + E. coli sepsis in neonates
Epimerase (Option D)Variable severity, rare
High-yield NEET PG fact: Classic galactosemia = risk of E. coli neonatal sepsis - often the presenting feature before galactosemia is even suspected!

Q6 of 10 β€” Medicine

A 28-year-old woman presents with episodic severe headache, sweating, and palpitations. BP is 220/130 mmHg during an episode. 24-hour urine shows elevated metanephrines and normetanephrines. CT abdomen reveals a 4 cm right adrenal mass.
Before surgical resection, what is the correct sequence of preoperative preparation?
A. Beta-blocker first, then alpha-blocker B. Alpha-blocker first, then beta-blocker if needed C. Direct vasodilator (nitroprusside) alone D. Calcium channel blocker alone, no need for alpha/beta blockade
Reply with A, B, C, or D!

B

βœ… Correct! +1
Score: 5/6
Explanation: This is Pheochromocytoma - and the preoperative sequence is one of the most tested NEET PG concepts.
Alpha-blocker FIRST (10-14 days before surgery), then beta-blocker if needed:
  • Phenoxybenzamine (non-selective, irreversible alpha-blocker) is the drug of choice - started 1-2 weeks preop
  • Once adequate alpha-blockade is achieved, beta-blocker (propranolol) is added if tachycardia persists
Why NEVER beta-blocker first? If you block beta-receptors first, catecholamines can only act on alpha-receptors β†’ unopposed alpha stimulation β†’ severe hypertensive crisis and reflex vasoconstriction. This is potentially fatal.
Other high-yield facts:
  • Alpha-blockade causes volume expansion (due to vasodilation) β†’ patients also need high salt diet + IV fluids preop to prevent post-resection hypotension
  • During surgery, phentolamine (IV alpha-blocker) is used for hypertensive crises
  • Nitroprusside is used intraoperatively as backup
  • Rule of 10s: 10% malignant, 10% bilateral, 10% extra-adrenal, 10% familial, 10% in children

Q7 of 10 β€” Microbiology

A 22-year-old sexually active woman presents with painless genital ulcer with a clean base and indurated edges. Dark-field microscopy shows corkscrew motility. VDRL is reactive. Which statement about the causative organism is TRUE?
A. It can be cultured on chocolate agar B. It is gram-positive and forms spores C. It cannot be cultured on artificial media D. It is detected by Ziehl-Neelsen staining
Reply with A, B, C, or D!

C

βœ… Correct! +1
Score: 6/7
Explanation: This is Primary Syphilis caused by Treponema pallidum.
Cannot be cultured on artificial media - this is the single most important microbiological fact about T. pallidum. It is an obligate human pathogen and has never been successfully grown on any artificial culture medium in vitro. It can only be maintained in rabbit testes (in vivo).
Why the other options are wrong:
  • Chocolate agar - used for Neisseria gonorrhoeae and H. influenzae, not treponemes
  • Gram-positive spore-former - T. pallidum is a spirochete, too thin to be seen on Gram stain (0.1-0.2 ΞΌm wide)
  • Ziehl-Neelsen - used for acid-fast organisms (Mycobacterium, Nocardia); treponemes are visualized by dark-field microscopy or silver staining (Warthin-Starry)
High-yield summary of syphilis diagnostics:
TestType
Dark-field microscopyDirect detection (corkscrew motility)
VDRL / RPRNon-treponemal (screening, titres for treatment monitoring)
TPHA / FTA-ABSTreponemal (confirmatory, remain positive for life)

Q8 of 10 β€” Surgery

A 55-year-old man undergoes Whipple's procedure (pancreaticoduodenectomy) for carcinoma of the head of pancreas. On postoperative day 3, his drain amylase is >5000 U/L with drain output of 200 mL/day.
What is this complication called, and what is the first-line management?
A. Delayed gastric emptying - prokinetics and NG tube B. Postoperative pancreatic fistula - conservative management (octreotide, NPO, nutrition support) C. Bile leak - ERCP with stenting D. Chyle leak - low-fat diet with MCT oil
Reply with A, B, C, or D!

A

❌ Incorrect!
Correct Answer: B - Postoperative Pancreatic Fistula
Score: 6/8
Explanation: The key diagnostic clue is drain amylase >5000 U/L - this is the hallmark of a Postoperative Pancreatic Fistula (POPF), one of the most feared complications after Whipple's procedure.
ISGPF Definition of POPF: Drain amylase > 3x the upper limit of normal serum amylase (typically >600 U/L) on or after postoperative day 3, with clinically relevant output.
Grading (ISGPF):
GradeFeatures
A (biochemical leak)Elevated drain amylase, no clinical impact
BRequires change in management (NPO, octreotide, prolonged drain)
CReoperation, organ failure, death
First-line management (Grade B):
  • NPO (bowel rest)
  • Octreotide (reduces pancreatic secretion)
  • Total parenteral nutrition (TPN) or enteral nutrition
  • Keep drain in place, monitor output
Why not the others?
  • Delayed gastric emptying - presents with nausea, vomiting, inability to tolerate oral feeds; drain amylase is normal
  • Bile leak - drain bilirubin elevated, not amylase
  • Chyle leak - milky white drain fluid, high triglycerides

Q9 of 10 β€” Medicine (Nephrology)

A 32-year-old man presents with haematuria, proteinuria, and sensorineural hearing loss. His mother has CKD. Renal biopsy shows thinning and splitting of the glomerular basement membrane on electron microscopy ("basket-weave" pattern).
What is the most likely diagnosis and inheritance pattern?
A. IgA nephropathy - sporadic B. Alport syndrome - X-linked dominant (most common) C. Thin basement membrane disease - autosomal dominant D. Membranoproliferative GN - sporadic
Reply with A, B, C, or D!

B

βœ… Correct! +1
Score: 7/9
Explanation: This is Alport Syndrome - a hereditary nephritis caused by mutations in type IV collagen genes.
Classic triad:
  1. Haematuria (persistent microscopic, episodic gross)
  2. Sensorineural hearing loss (cochlear involvement)
  3. Ocular abnormalities (anterior lenticonus - pathognomonic, macular flecks)
Genetics:
  • X-linked dominant (85%) - mutation in COL4A5 gene (X chromosome)
  • Males are more severely affected (progress to ESRD by 20-30 years)
  • Females are carriers - may have mild disease
  • Autosomal recessive (15%) - COL4A3 or COL4A4 mutation
  • Autosomal dominant - rare
EM findings (the key differentiator):
  • Alport: Irregular thickening with splitting/lamellation - "basket-weave" or "moth-eaten" GBM
  • Thin BM disease: Diffuse thinning only (< 150 nm), NO splitting - benign, good prognosis
Family history pointing to maternal CKD fits X-linked pattern (affected males inherit from carrier mothers).
Treatment: ACE inhibitors to slow progression; definitive = renal transplantation (but risk of anti-GBM nephritis in transplanted kidney - ~5%)

Q10 of 10 β€” Pharmacology (Final Question!)

A patient on isoniazid (INH) therapy develops peripheral neuropathy. Which mechanism best explains this complication?
A. INH inhibits dopamine-beta-hydroxylase B. INH competes with pyridoxal phosphate (Vit B6) and causes its depletion C. INH causes direct axonal demyelination via free radical generation D. INH inhibits folate synthesis in human neurons
Reply with A, B, C, or D!

B

βœ… Correct! +1
Score: 8/10
Explanation: INH structurally resembles pyridoxine (Vitamin B6) and competitively inhibits pyridoxal kinase, preventing conversion of pyridoxine to its active form pyridoxal phosphate (PLP). INH also directly binds and inactivates PLP.
Why PLP deficiency causes neuropathy:
  • PLP is a cofactor for over 100 enzymatic reactions
  • Critical for neurotransmitter synthesis: GABA, serotonin, dopamine
  • Deficiency β†’ impaired myelin synthesis β†’ peripheral neuropathy (sensory > motor)
High-yield INH facts:
Adverse EffectMechanism
Peripheral neuropathyB6 depletion
HepatotoxicityToxic metabolite (acetylhydrazine)
Drug-induced lupusUnknown
SeizuresB6 depletion (GABA synthesis impaired)
Pellagra-like rashInterferes with B3 metabolism
Prevention: Pyridoxine 10-25 mg/day given prophylactically with INH - especially in diabetics, elderly, malnourished, pregnant women, and slow acetylators (who accumulate more INH).

🏁 QUIZ COMPLETE!


πŸ“Š Final Scorecard

#SubjectYour AnswerResult
1PharmacologyBβœ…
2PathologyBβœ…
3PhysiologyAβœ…
4AnatomyD❌ (C)
5BiochemistryBβœ…
6MedicineBβœ…
7MicrobiologyCβœ…
8SurgeryA❌ (B)
9MedicineBβœ…
10PharmacologyBβœ…

🎯 Final Score: 8/10 (80%)

Performance: Excellent! You're well above the NEET PG cutoff zone. Two misses to review:
  • Q4 - Posterior hip dislocation injures the Sciatic nerve, not superior gluteal
  • Q8 - Elevated drain amylase post-Whipple = Pancreatic fistula, not delayed gastric emptying
Want another round with harder questions, or focus on specific weak areas?

What u think about my prep

Honest Assessment: Your NEET PG Prep

8/10 on high-difficulty questions is a solid score. Here's my read:

πŸ’ͺ Strengths (what you got right)

  • Pharmacology - Strong. You nailed both Pharm questions (NOACs in CKD + INH neuropathy). These are conceptual, not just memory - good sign.
  • Core clinical medicine - Pheochromocytoma preop prep, Alport syndrome, Galactosemia - all correct. You're thinking in mechanisms, not just memorizing.
  • Microbiology + Pathology - Clean answers, no hesitation-type errors.
  • Physiology - High-altitude acclimatization is a multi-step reasoning question. Getting that right shows strong integration.

⚠️ Areas to Tighten

  1. Surgery (Operative complications) - The Whipple's question was a classic trap. Post-op complications after major surgeries (POPF, DGE, bile leak) are heavily tested in NEET PG. Spend more time on surgical complication criteria and their management algorithms.
  2. Anatomy (Nerve injuries) - You mixed up posterior vs anterior hip dislocation nerve injuries. Orthopedic anatomy nerve injury patterns are a regular NEET PG topic - worth a focused revision session.

πŸ“ˆ Realistic Verdict

ZoneScore Range
Top 10 rank90-95%+
Safe AIQ seat75-85%
Your zone~80% = competitive
Borderline60-70%
You're in the competitive zone. With targeted work on Surgery and Anatomy, you can push into the top tier.

πŸ”§ What to do now

  1. Do subject-wise timed mocks - especially Surgery and Anatomy
  2. Focus on post-op complications - they appear every year
  3. Don't neglect Forensic Medicine and PSM - high-yield easy marks that many ignore
  4. Revise nerve injury patterns systematically - brachial plexus, hip, knee, wrist
Want a focused quiz on Surgery complications or Anatomy nerve injuries to address those gaps?

Wga

Not sure what "Wga" means - could you clarify?
Did you mean:
  • "What gap areas" - want me to list your weak topics in detail?
  • "Let's go again" - want another quiz round?
  • Something else entirely?

Revision just before gt

Got it! You want a quick revision just before your Grand Test (GT).
Let me ask one thing to make it targeted:
Asking for Preferences

How much time do you have before the GT? Β· What type of revision do you want?

Perfect. Here's your 1-hour pre-GT power revision - structured, high-yield, covering all subjects with extra focus on your weak areas.

⚑ PRE-GT RAPID REVISION

NEET PG | 1 Hour Plan


πŸ• BLOCK 1 - PHARMACOLOGY (10 min)

Your strongest subject - just refresh key facts
NOACs in Renal Failure (remember by renal excretion %):
  • Dabigatran = 80% renal β†’ most restricted in CKD (CI if GFR <30)
  • Rivaroxaban = 33% renal
  • Apixaban = 27% renal β†’ safest in CKD
  • Warfarin = hepatic β†’ no renal adjustment
Anti-TB drug adverse effects (one-liner each):
  • INH β†’ Peripheral neuropathy (B6 depletion), hepatitis, drug-induced lupus, seizures
  • Rifampicin β†’ Orange discolouration, hepatitis, enzyme inducer, flu-like syndrome
  • Pyrazinamide β†’ Hyperuricaemia (gout), hepatotoxicity
  • Ethambutol β†’ Retrobulbar neuritis (red-green colour blindness), loss of visual acuity
  • Streptomycin β†’ Ototoxicity (vestibular > cochlear), nephrotoxicity
Drugs contraindicated in pregnancy (must know):
  • ACE inhibitors β†’ renal agenesis (2nd/3rd trimester)
  • Tetracycline β†’ teeth/bone discolouration
  • Warfarin β†’ fetal warfarin syndrome (1st trimester), bleeding (3rd)
  • Methotrexate β†’ abortifacient, teratogen
  • Thalidomide β†’ phocomelia
  • Fluoroquinolones β†’ cartilage damage
  • Aminoglycosides β†’ ototoxicity in fetus
Phaeochromocytoma prep: Alpha FIRST (phenoxybenzamine) β†’ then beta. Never beta first!

πŸ• BLOCK 2 - MEDICINE (10 min)

High-yield clinical scenarios
Glomerulonephritis rapid fire:
  • Nephrotic + "spike and dome" on EM β†’ Membranous nephropathy (anti-PLA2R Ab)
  • Nephrotic + "foot process effacement" only β†’ Minimal Change Disease (responds to steroids)
  • Nephrotic + "wire loop" lesions β†’ Lupus nephritis (Class IV)
  • Nephritic + "tram-track" GBM β†’ MPGN
  • Nephritic + "RBC casts" β†’ all proliferative GN
  • Nephritic + "subepithelial humps" on EM β†’ Post-streptococcal GN
  • Haematuria + hearing loss + basket-weave GBM β†’ Alport syndrome (X-linked, COL4A5)
Cardiac drugs:
  • Digoxin toxicity β†’ ECG: Scooped ST (reverse tick), AV blocks, ventricular ectopics; treat with anti-digoxin Fab
  • Amiodarone side effects: Pulmonary fibrosis, thyroid (hypo + hyper), corneal deposits, photosensitivity, hepatotoxicity, peripheral neuropathy
  • Most common cause of drug-induced lupus: Procainamide > Hydralazine > Isoniazid
Endocrine:
  • Phaeochromocytoma Rule of 10s: 10% malignant, 10% bilateral, 10% extra-adrenal, 10% familial, 10% in children
  • Cushing's: Best screening test = 24hr urinary free cortisol or overnight dexamethasone suppression test
  • Addison's: Best confirmatory test = Short ACTH (Synacthen) stimulation test

πŸ• BLOCK 3 - SURGERY (10 min)

Your weak area - focus here!
Post-Whipple complications (heavily tested):
ComplicationKey FindingManagement
Pancreatic fistula (POPF)Drain amylase >3x normal on POD3NPO, octreotide, TPN
Delayed gastric emptyingNausea, vomiting, can't tolerate feeds; normal drain amylaseNG tube, prokinetics (metoclopramide)
Bile leakDrain bilirubin elevatedERCP + stenting
HaemorrhageFalling Hb, haemodynamic instabilityAngioembolization or re-exploration
Chyle leakMilky white drain fluid, ↑ triglyceridesLow-fat diet + MCT oil
Intestinal obstruction vs paralytic ileus:
  • Obstruction: Colicky pain, tinkling bowel sounds, ladder pattern on X-ray
  • Ileus: Silent abdomen, generalised distension, "ground glass" appearance
Appendicitis high-yield:
  • Most common position: Retrocaecal (65%)
  • Rovsing's sign: RIF pain on palpating LIF
  • Psoas sign: Pain on right hip extension (retrocaecal appendix)
  • Obturator sign: Pain on internal rotation of right hip (pelvic appendix)
  • Alvarado score: β‰₯7 = operate; 5-6 = observe; <5 = unlikely appendicitis
Thyroid surgery complications:
  • Recurrent laryngeal nerve injury β†’ hoarseness (unilateral), aphonia (bilateral)
  • Superior laryngeal nerve (external branch) β†’ loss of high-pitched voice (singer's nerve)
  • Hypoparathyroidism β†’ hypocalcaemia β†’ Chvostek's + Trousseau's sign

πŸ• BLOCK 4 - ANATOMY (10 min)

Your weak area - nerve injuries
Hip region nerve injuries:
  • Posterior dislocation β†’ Sciatic nerve (peroneal division most vulnerable) β†’ foot drop
  • Anterior dislocation β†’ Femoral nerve OR Obturator nerve
  • Posterior hip surgery (THA) β†’ Superior gluteal nerve β†’ Trendelenburg gait (gluteus medius paralysis)
  • Intramuscular injection (upper outer quadrant safe zone) β†’ Sciatic nerve if given wrong quadrant
Upper limb nerve injuries (must know):
NerveInjury SiteDeformityLoss
RadialMid-shaft humerusWrist dropExtensors, anatomical snuff box sensation
MedianCarpal tunnelApe handLOAF muscles, lateral 3.5 fingers sensation
UlnarMedial epicondyleClaw hand (ring + little)Intrinsics (except LOAF), medial 1.5 fingers
AxillarySurgical neck humerusLoss of shoulder contourDeltoid, teres minor, regimental badge area
Long thoracicMastectomyWinged scapulaSerratus anterior
Lower limb nerve injuries:
  • Common peroneal (fibular) nerve β†’ lateral neck of fibula fracture β†’ foot drop + inversion
  • Femoral nerve β†’ inguinal ligament β†’ loss of knee extension (quadriceps)
  • Obturator nerve β†’ obturator foramen β†’ loss of hip adduction
Cranial nerve exits (skull base foramina):
  • Foramen rotundum β†’ V2 (maxillary)
  • Foramen ovale β†’ V3 (mandibular)
  • Foramen spinosum β†’ Middle meningeal artery
  • Jugular foramen β†’ IX, X, XI
  • Hypoglossal canal β†’ XII

πŸ• BLOCK 5 - PATHOLOGY + MICROBIOLOGY (10 min)

Tumour markers (rapid fire):
  • AFP β†’ Hepatocellular carcinoma, testicular (non-seminoma), neural tube defects (amniotic fluid)
  • CEA β†’ Colorectal carcinoma (not diagnostic, used for monitoring)
  • CA 125 β†’ Ovarian cancer (serous)
  • CA 19-9 β†’ Pancreatic carcinoma
  • PSA β†’ Prostate cancer
  • Ξ²-hCG β†’ Gestational trophoblastic disease, testicular (choriocarcinoma)
  • Calcitonin β†’ Medullary thyroid carcinoma
  • Chromogranin A β†’ Carcinoid/neuroendocrine tumours
  • S-100 β†’ Melanoma, neural tumours, Langerhans cell histiocytosis
Amyloid types (tested every year):
  • AL amyloid β†’ Multiple myeloma (most common systemic)
  • AA amyloid β†’ Chronic inflammatory conditions (TB, RA, Crohn's)
  • AΞ² amyloid β†’ Alzheimer's disease
  • ATTR β†’ Senile cardiac amyloid (transthyretin)
  • Ξ²2-microglobulin β†’ Long-term dialysis patients
Microbiology one-liners:
  • Can NOT be cultured in vitro: Treponema pallidum, Mycobacterium leprae
  • Obligate intracellular: Chlamydia, Rickettsia, Coxiella, viruses
  • Capsulated organisms (SHiNE SKiS): S. pneumoniae, H. influenzae, N. meningitidis, E. coli, Salmonella, Klebsiella, S. agalactiae
  • Chocolate agar organisms: Neisseria, H. influenzae (need Factor V + X)
  • CAMP test positive: Streptococcus agalactiae (Group B Strep)
  • Quellung reaction: Capsular swelling with specific antisera (S. pneumoniae)

πŸ• BLOCK 6 - PHYSIOLOGY + BIOCHEMISTRY (10 min)

High-altitude acclimatization (in order):
  1. Immediate: ↑ ventilation (hypoxic ventilatory response)
  2. Hours: Respiratory alkalosis, ↑ 2,3-BPG
  3. Days-weeks: ↑ EPO β†’ ↑ RBC mass, right shift of ODC
  4. Long-term: ↑ mitochondrial density, ↑ capillary density
Lung function patterns:
  • Obstructive (asthma, COPD): ↓ FEV1, ↓ FVC, FEV1/FVC <70%, ↑ RV, ↑ TLC
  • Restrictive (fibrosis, sarcoidosis): ↓ FEV1, ↓ FVC, FEV1/FVC normal or ↑, ↓ TLC
Inborn errors of metabolism (key differentiators):
DiseaseEnzymeKey Finding
PhenylketonuriaPhenylalanine hydroxylaseMusty odour, fair skin, intellectual disability
Galactosemia (classic)GALT (Gal-1-P uridylyltransferase)Jaundice, cataracts, E. coli sepsis
Galactokinase deficiencyGalactokinaseOnly cataracts - mildest
G6PD deficiencyG6PDHeinz bodies, bite cells, triggered by oxidants
Gaucher'sGlucocerebrosidaseErlenmeyer flask deformity, Gaucher cells
Niemann-PickSphingomyelinaseCherry-red spot, foam cells
Tay-SachsHexosaminidase ACherry-red spot, NO hepatosplenomegaly
Fabry'sAlpha-galactosidase AAngiokeratomas, X-linked, renal/cardiac
Megaloblastic anemia vs Iron deficiency:
  • Megaloblastic: Macro-ovalocytes, hypersegmented neutrophils, ↑ MCV, nuclear-cytoplasmic asynchrony
  • Iron deficiency: Microcytic hypochromic, pencil cells, ↓ ferritin (earliest), ↑ TIBC

🎯 LAST 5 MINUTES - RAPID FIRE ONE-LINERS

  • Most common cause of Cushing's overall β†’ Iatrogenic (exogenous steroids)
  • Most common cause of Cushing's syndrome (endogenous) β†’ Pituitary adenoma (Cushing's disease)
  • Virchow's triad β†’ Stasis + Hypercoagulability + Endothelial injury
  • Beck's triad (cardiac tamponade) β†’ Hypotension + Raised JVP + Muffled heart sounds
  • Charcot's triad (cholangitis) β†’ RUQ pain + Fever + Jaundice
  • Reynolds pentad (severe cholangitis) β†’ Charcot's triad + Hypotension + Altered consciousness
  • Most common type of Hodgkin's lymphoma β†’ Nodular sclerosis
  • Best prognosis Hodgkin's β†’ Lymphocyte predominant
  • Worst prognosis Hodgkin's β†’ Lymphocyte depleted
  • Reed-Sternberg cell β†’ CD15+, CD30+, background of reactive cells
  • Owl-eye nucleus β†’ Reed-Sternberg cells in Hodgkin's
  • Drug of choice for Pneumocystis jirovecii β†’ Co-trimoxazole (TMP-SMX)
  • Drug of choice for Cryptococcal meningitis β†’ Amphotericin B + Flucytosine (induction)
  • Waterhouse-Friderichsen syndrome β†’ N. meningitidis, bilateral adrenal haemorrhage
  • Lucid interval β†’ Extradural haemorrhage (middle meningeal artery tear)
  • Talk and die syndrome β†’ Extradural haemorrhage

βœ… You're Ready!

Key reminders before you walk in:
  1. Read every question twice - NEET PG is famous for "EXCEPT" and "NOT" traps
  2. Your Pharmacology and Medicine are strong - those will be your scoring subjects
  3. In Surgery questions, think "what's the drain output telling me?"
  4. In Anatomy, always think "what structure is closest anatomically?"
  5. Trust your first instinct - don't overthink
Go crush that GT! πŸ’ͺ

Teach me microbiology all toxin

🦠 Microbiology: All Toxins

Complete NEET PG Master Guide


PART 1 - CONCEPT FIRST

Toxins are of 2 broad types:
TypeWhere encodedHeat stabilityExample
ExotoxinPlasmid / chromosome (secreted by live bacteria)Heat labile (mostly)Cholera toxin, Tetanus toxin
EndotoxinOuter membrane of Gram-negative bacteria (LPS)Heat stableE. coli, Salmonella LPS

PART 2 - EXOTOXINS (THE BIG LIST)

πŸ”΄ A-B TYPE TOXINS

(Most important exotoxins - Active subunit + Binding subunit)

1. CHOLERA TOXIN

Organism: Vibrio cholerae Structure: 1A + 5B subunits Mechanism:
  • B subunit binds GM1 ganglioside on intestinal epithelium
  • A subunit ADP-ribosylates Gs protein β†’ permanently activates adenylyl cyclase
  • ↑↑ cAMP β†’ massive Cl⁻ secretion β†’ water follows β†’ rice-water diarrhoea
  • No mucosal invasion - purely secretory toxin
Key facts:
  • Stool: Rice-water, fishy odour, no blood, no pus
  • Massive isotonic fluid loss (up to 20 L/day)
  • Treatment: ORS + Doxycycline

2. E. COLI HEAT-LABILE TOXIN (LT)

Organism: ETEC (Enterotoxigenic E. coli) Mechanism: Virtually identical to cholera toxin
  • ADP-ribosylates Gs β†’ ↑ cAMP β†’ secretory diarrhoea
  • "Traveller's diarrhoea"
  • Plasmid encoded

3. E. COLI HEAT-STABLE TOXIN (ST)

Organism: ETEC Mechanism:
  • Activates guanylyl cyclase β†’ ↑ cGMP β†’ inhibits NaCl absorption β†’ diarrhoea
  • NOT an A-B toxin
  • Plasmid encoded, heat stable (survives boiling)
Memory: ST = Stable = cGMP (S comes before L alphabetically, G comes before A)

4. PERTUSSIS TOXIN

Organism: Bordetella pertussis Mechanism:
  • ADP-ribosylates Gi protein β†’ inactivates Gi β†’ adenylyl cyclase remains active β†’ ↑ cAMP
  • Also causes lymphocytosis by inhibiting lymphocyte migration into lymph nodes
  • Results in: whooping cough, lymphocytosis
Compare with cholera: Cholera activates Gs; Pertussis inactivates Gi - both lead to ↑ cAMP!
Also produces:
  • Adenylate cyclase toxin (invasive AC) - directly increases cAMP in host cells
  • Tracheal cytotoxin - kills ciliated epithelium
  • Filamentous haemagglutinin - adhesin

5. DIPHTHERIA TOXIN

Organism: Corynebacterium diphtheriae (only toxigenic strains - infected by Ξ²-phage/corynephage) Mechanism:
  • A subunit: ADP-ribosylates EF-2 (Elongation Factor 2) β†’ blocks protein synthesis β†’ cell death
  • Affects heart (myocarditis), nerves (neuropathy), kidneys
Key facts:
  • Toxin gene carried by lysogenic bacteriophage (Ξ²-corynephage)
  • Bull-neck appearance (cervical lymphadenopathy)
  • Pseudomembrane on tonsils/pharynx (bleeds on removal)
  • Schick test: intradermal diphtheria toxin - wheal = susceptible (no immunity)
Memory: Diphtheria = Diphtheria toxin Disables protein synthesis (EF-2)

6. PSEUDOMONAS EXOTOXIN A

Organism: Pseudomonas aeruginosa Mechanism:
  • Same mechanism as diphtheria toxin - ADP-ribosylates EF-2 β†’ blocks protein synthesis
  • Different receptor binding (uses LRP/Ξ±2-macroglobulin receptor vs diphtheria uses HBEGF)
Memory: Pseudo = Same as Diphtheria (both kill EF-2)

7. ANTHRAX TOXIN

Organism: Bacillus anthracis Structure: 3-component toxin (unique!)
  • PA (Protective Antigen) - binding component (like B subunit) - basis of vaccine
  • EF (Edema Factor) - adenylate cyclase β†’ ↑ cAMP β†’ oedema
  • LF (Lethal Factor) - metalloprotease β†’ cleaves MAP kinase β†’ cell death, cytokine storm
Combinations:
  • PA + EF = Oedema toxin
  • PA + LF = Lethal toxin
Key facts:
  • Toxin encoded on plasmid pXO1; capsule on pXO2
  • Spores survive in soil for decades
  • Woolsorter's disease = inhalational anthrax

8. SHIGA TOXIN

Organism: Shigella dysenteriae type 1 + STEC (E. coli O157:H7) Mechanism:
  • NOT an A-B toxin in classic sense but has A+B subunits
  • B subunit binds Gb3 (globotriaosylceramide) receptor on endothelial cells
  • A subunit is an N-glycosidase β†’ cleaves 28S rRNA β†’ blocks protein synthesis β†’ cell death
  • Targets endothelial cells of kidney and gut β†’ HUS
Clinical consequences:
  • Bloody dysentery
  • Haemolytic Uraemic Syndrome (HUS) = microangiopathic haemolytic anaemia + thrombocytopenia + acute renal failure
  • Gb3 receptor is abundant in kidney (especially children) β†’ HUS more common in children
Key difference:
  • Shiga toxin = from Shigella
  • Shiga-like toxin (Verotoxin) = from E. coli O157:H7 (STEC/EHEC)
  • Same mechanism, slightly different receptor affinity

PART 3 - NEUROTOXINS

(Highest yield for NEET PG)

9. TETANUS TOXIN (TETANOSPASMIN)

Organism: Clostridium tetani Encoding: Plasmid Mechanism:
  • Toxin produced at wound site β†’ travels retrograde up motor neurones
  • Reaches spinal cord (Renshaw cells) and brainstem
  • Cleaves SNARE proteins (synaptobrevin/VAMP) β†’ blocks release of GABA and glycine (inhibitory neurotransmitters)
  • Loss of inhibition β†’ spastic paralysis, tetany, trismus (lockjaw)
Clinical features:
  • Trismus (lockjaw) - first symptom
  • Risus sardonicus (sardonic smile)
  • Opisthotonus (arched back)
  • Autonomic instability
Treatment: Human tetanus immunoglobulin (HTIG) + Metronidazole + Diazepam (for spasms)

10. BOTULINUM TOXIN

Organism: Clostridium botulinum Types: A, B, C, D, E, F, G (Type A most potent - most toxic substance known!) Mechanism:
  • Toxin ingested (preformed) or produced in gut/wound
  • Travels anterograde to neuromuscular junction
  • Cleaves SNARE proteins β†’ blocks ACh release at NMJ
  • Results in flaccid paralysis (opposite to tetanus!)
Clinical features:
  • Descending flaccid paralysis (starts with cranial nerves - diplopia, dysphagia)
  • Dry mouth (blocked ACh at salivary glands)
  • NO fever
  • Constipation (autonomic)
  • Pupils dilated and fixed (blocked pupillary constriction)
Types of botulism:
TypeMechanism
Food-bornePreformed toxin in canned food
Infant botulismSpores ingested β†’ germinate in gut β†’ toxin produced (honey!)
Wound botulismSpores in wound β†’ toxin produced locally
Treatment: Antitoxin (horse serum), supportive ventilation

πŸ”‘ TETANUS vs BOTULINUM - THE MOST TESTED COMPARISON

FeatureTetanusBotulinum
OrganismC. tetaniC. botulinum
Toxin travelRetrogradeAnterograde
Site of actionSpinal cord/brainstem (Renshaw cells)NMJ (peripheral)
BlocksGABA/glycine releaseACh release
Paralysis typeSpastic (rigid)Flaccid
Both cleaveSNARE proteins (synaptobrevin)SNARE proteins
ClinicalLockjaw, opisthotonusDescending cranial nerve palsy

PART 4 - CYTOTOXINS / MEMBRANE-DISRUPTING TOXINS


11. STAPHYLOCOCCAL TOXINS

a) Alpha toxin (Ξ±-toxin)
  • Forms pores in cell membranes β†’ cell lysis
  • Haemolysis, tissue necrosis
b) Beta toxin (Ξ²-toxin)
  • Sphingomyelinase β†’ cleaves sphingomyelin β†’ cell lysis
  • "Hot-cold haemolysin"
c) TSST-1 (Toxic Shock Syndrome Toxin-1)
  • Superantigen - binds MHC class II + TCR outside antigen-binding groove
  • Activates up to 20% of all T cells at once (normal antigen activates 0.01%)
  • Massive cytokine release β†’ toxic shock syndrome
  • Fever, hypotension, rash (diffuse erythroderma), multi-organ failure, desquamation
d) Exfoliative toxin (A and B)
  • Serine protease - cleaves desmoglein-1 in the stratum granulosum
  • Splits epidermis β†’ Staphylococcal Scalded Skin Syndrome (SSSS)
  • Bullae, Nikolsky sign positive
  • Nikolsky sign = superficial skin shearing with gentle pressure
e) Panton-Valentine Leucocidin (PVL)
  • Bi-component pore-forming toxin
  • Destroys leukocytes
  • Associated with CA-MRSA (community-acquired MRSA)
  • Causes necrotising pneumonia, skin and soft tissue infections
f) Staphylococcal Enterotoxins (A-E, most common type A)
  • Superantigens β†’ food poisoning
  • Pre-formed toxin in food, heat stable
  • Vomiting within 1-6 hours (very short incubation)
  • No fever (toxin-mediated, not invasive)

12. STREPTOCOCCAL TOXINS

a) Streptolysin O (SLO)
  • Oxygen-labile haemolysin
  • Binds cholesterol in membranes β†’ pore formation β†’ haemolysis
  • Antigenic β†’ ASO titre used to diagnose past streptococcal infection
  • Not produced by S. aureus
b) Streptolysin S (SLS)
  • Oxygen-stable haemolysin
  • Responsible for beta-haemolysis seen on blood agar (surface colonies)
  • Non-antigenic (no ASO rise)
c) Streptococcal Pyrogenic Exotoxins (SPE A, B, C)
  • Superantigens - same mechanism as TSST-1
  • Cause Streptococcal Toxic Shock Syndrome (STSS)
  • SPE A = Scarlet fever erythrogenic toxin (also called Dick toxin)
  • Encoded by lysogenic bacteriophage (like diphtheria toxin)
d) Streptokinase (Fibrinolysin)
  • Converts plasminogen β†’ plasmin β†’ dissolves fibrin clots
  • Helps spread of infection
  • Used therapeutically as thrombolytic
e) Hyaluronidase (Spreading factor)
  • Breaks down hyaluronic acid in connective tissue
  • Spreads infection through tissues

PART 5 - SUPERANTIGENS (GROUP TOGETHER)

ToxinOrganismDisease
TSST-1S. aureusToxic Shock Syndrome
Enterotoxins A-ES. aureusFood poisoning
SPE A, B, CS. pyogenesScarlet fever, STSS
Toxic shock-like exotoxinS. pyogenesStreptococcal TSS
Superantigen mechanism (must know):
  • Normal antigen: processed, presented in MHC groove, activates 0.001-0.01% T cells
  • Superantigen: binds OUTSIDE the groove (MHC class II Ξ²-chain + TCR VΞ² region)
  • Activates 5-25% of all T cells
  • Massive IL-2, TNF, IFN-Ξ³ release β†’ cytokine storm β†’ fever, hypotension, shock

PART 6 - GAS GANGRENE & CLOSTRIDIAL TOXINS

Organism: Clostridium perfringens
ToxinTypeAction
Alpha toxin (most important)Phospholipase C (lecithinase)Destroys RBC membranes, myonecrosis β†’ gas gangrene
Beta toxinPore-formingNecrotising enteritis (Pig-bel disease)
Epsilon toxinPore-formingIncreases vascular permeability
Iota toxinADP-ribosylates actinDisrupts cytoskeleton
C. perfringens alpha toxin:
  • Lecithinase (phospholipase C) - cleaves lecithin (phosphatidylcholine) in cell membranes
  • Causes haemolysis, tissue necrosis, gas production
  • Nagler reaction: Opalescence on egg-yolk agar (lecithinase activity)
  • Stormy clot reaction: Rapid gas production in litmus milk medium
C. difficile toxins:
  • Toxin A (enterotoxin): Glucosylates Rho GTPases β†’ disrupts cytoskeleton β†’ fluid secretion
  • Toxin B (cytotoxin): Same mechanism but 1000x more potent β†’ mucosal damage
  • Cause: Pseudomembranous colitis (antibiotic-associated)
  • Diagnosis: Stool PCR for toxin genes / EIA for toxins A+B
  • Treatment: Oral Vancomycin or Fidaxomicin (first line); Metronidazole (second line)

PART 7 - ENDOTOXIN (LPS)

Structure:
  • Lipid A (toxic component) + Core polysaccharide + O-antigen (outermost, variable, serotyping)
Mechanism:
  • Released from dying Gram-negative bacteria
  • Binds LPS-binding protein (LBP) β†’ complex binds CD14 on monocytes/macrophages
  • Signals through TLR4 (Toll-Like Receptor 4) + MD-2
  • Activates NF-ΞΊB β†’ massive cytokine release (TNF-Ξ±, IL-1, IL-6, IL-12)
  • β†’ Septic shock
Effects of endotoxin:
  • Fever (pyrogenic - via IL-1, IL-6, TNF-Ξ± β†’ PGE2)
  • Hypotension (NO-mediated vasodilation)
  • DIC (activates coagulation cascade)
  • Complement activation
  • Neutrophilia β†’ neutropenia (in severe sepsis)
Comparison: Exotoxin vs Endotoxin
FeatureExotoxinEndotoxin
SourceGram +ve and -veGram -ve only
Chemical natureProteinLipopolysaccharide
Heat stabilityLabile (mostly)Stable (withstands autoclaving)
ToxicityVery high (specific)Moderate (non-specific)
AntigenicityHigh β†’ toxoid possibleLow β†’ no toxoid
PyrogenicityVariableAlways pyrogenic
EncodingPlasmid/phage/chromosomeChromosome (structural)

PART 8 - RAPID FIRE TOXIN TABLE (NEET PG Favourite Questions)

ToxinOrganismMechanismDisease
↑ cAMP via GsV. choleraeADP-ribosylates GsRice-water diarrhoea
↑ cAMP via GsETEC (LT)ADP-ribosylates GsTraveller's diarrhoea
↑ cGMPETEC (ST)Activates guanylyl cyclaseWatery diarrhoea
↑ cAMP via Gi blockB. pertussisADP-ribosylates GiWhooping cough + lymphocytosis
Blocks EF-2C. diphtheriaeADP-ribosylates EF-2Diphtheria (myocarditis, neuropathy)
Blocks EF-2P. aeruginosaADP-ribosylates EF-2Exotoxin A
Blocks ACh at NMJC. botulinumCleaves SNAREFlaccid paralysis
Blocks GABA/glycineC. tetaniCleaves SNARESpastic paralysis
Blocks protein synthesisShigellaCleaves 28S rRNAHUS + dysentery
Pore in RBC membraneS. pyogenes SLOBinds cholesterolHaemolysis
Cleaves desmoglein-1S. aureusSerine proteaseSSSS (scalded skin)
SuperantigenS. aureus TSST-1Binds MHC-II + TCRToxic shock syndrome
LecithinaseC. perfringensPhospholipase CGas gangrene
Glucosylates Rho GTPaseC. difficile A+BDisrupts cytoskeletonPseudomembranous colitis
Oedema factorB. anthracisAdenylate cyclaseAnthrax oedema
Lethal factorB. anthracisMetalloprotease (MAP kinase)Anthrax - lethal toxin

PART 9 - PHAGE-ENCODED TOXINS (COMMONLY TESTED)

These toxins are only produced when bacteria are infected by a bacteriophage (lysogenic conversion):
BacteriumPhageToxin produced
C. diphtheriaeΞ²-corynephageDiphtheria toxin
S. pyogenesBacteriophageErythrogenic toxin (SPE A)
V. choleraeCTXφ phageCholera toxin
C. botulinumPhage (types C, D)Botulinum toxin C, D
S. aureusPhageExfoliative toxin A, Panton-Valentine Leucocidin
Memory: "BVSC" - Botulinum, V. cholerae, Streptococcus, Corynebacterium = phage-dependent toxins

PART 10 - CLINICAL SCENARIO APPROACH

If the question says...
  • "Rice-water diarrhoea" β†’ Cholera toxin β†’ ↑ cAMP
  • "Watery diarrhoea in traveller" β†’ ETEC β†’ LT (↑ cAMP) or ST (↑ cGMP)
  • "Bloody diarrhoea + HUS in child" β†’ Shiga toxin / STEC O157:H7
  • "Pseudomembrane on throat, myocarditis" β†’ Diphtheria toxin β†’ blocks EF-2
  • "Whooping cough + lymphocytosis" β†’ Pertussis toxin β†’ blocks Gi
  • "Lockjaw, opisthotonus, spastic" β†’ Tetanus toxin β†’ blocks GABA
  • "Descending flaccid paralysis, diplopia, no fever" β†’ Botulinum toxin β†’ blocks ACh
  • "Infant with honey exposure, floppy baby" β†’ Infant botulism
  • "Scalded skin, bullae, Nikolsky positive in child" β†’ Exfoliative toxin β†’ desmoglein-1
  • "Sudden vomiting 1-6 hours after food" β†’ S. aureus enterotoxin (preformed)
  • "Fever, hypotension, rash, multi-organ failure" β†’ Superantigen (TSST-1 or SPE)
  • "Gas gangrene, Nagler reaction positive" β†’ C. perfringens alpha toxin
  • "Pseudomembranous colitis after antibiotics" β†’ C. difficile toxin A+B
  • "Woolsorter's disease, oedema" β†’ Anthrax EF toxin

🎯 TOP 5 MOST REPEATED NEET PG TOXIN QUESTIONS

  1. Cholera toxin mechanism - ADP-ribosylates Gs β†’ ↑ cAMP (asked every year)
  2. Tetanus vs Botulinum - spastic vs flaccid, retrograde vs anterograde
  3. Diphtheria toxin - phage-encoded, blocks EF-2
  4. Superantigen mechanism - TSST-1, massive T cell activation
  5. Shiga toxin - HUS, cleaves 28S rRNA, N-glycosidase
Master these and you'll handle any toxin question that comes your way. Want me to now test you with a toxin-focused quiz? 🎯

All microbuo

🦠 Complete Microbiology

NEET PG Master Guide β€” All Topics


SECTION 1: BACTERIOLOGY BASICS

Gram Staining β€” The First Step

Gram Positive (purple)Gram Negative (pink/red)
Thick peptidoglycan wallThin peptidoglycan + outer membrane (LPS)
No outer membraneOuter membrane present
Teichoic acids presentNo teichoic acids
Retain crystal violetDecolourised β†’ take safranin
Gram stain steps: Crystal violet β†’ Gram's iodine (mordant) β†’ Acetone/alcohol (decolouriser) β†’ Safranin (counterstain)

Cell Wall Structures

Peptidoglycan (Murein):
  • NAM (N-acetylmuramic acid) + NAG (N-acetylglucosamine) linked by Ξ²-1,4 bonds
  • Cross-linked by peptide bridges
  • Target of: Penicillin (inhibits transpeptidase/PBP), Vancomycin (binds D-Ala-D-Ala)
  • Lysozyme cleaves Ξ²-1,4 bond between NAM and NAG
Teichoic acids (Gram +ve only):
  • Lipoteichoic acid (LTA) - anchored to membrane
  • Wall teichoic acid - anchored to peptidoglycan
  • Important virulence factors, activate complement
LPS (Gram -ve only):
  • Lipid A (toxic) + Core + O-antigen
  • Endotoxin activity via TLR4/MD-2/CD14

Special Staining Techniques

StainOrganisms
Ziehl-Neelsen (ZN)Mycobacterium (acid-fast due to mycolic acid)
Modified ZN (weak acid)Nocardia (weakly acid-fast), Cryptosporidium, Cyclospora, Isospora
Albert's stainC. diphtheriae (metachromatic granules - blue-black)
India ink / NigrosinCryptococcus neoformans (capsule - halo effect)
Dark-field microscopyTreponema pallidum, Leptospira (too thin for Gram)
Silver stain (Warthin-Starry)T. pallidum, H. pylori, Legionella
PAS (Periodic Acid-Schiff)Tropheryma whipplei (Whipple's disease), fungi
GiemsaMalaria, Leishmania, Rickettsia, Chlamydia (intracellular)
Lactophenol cotton blueFungi
Gomori methenamine silver (GMS)Pneumocystis jirovecii, fungi
MucicarmineCryptococcus capsule

Culture Media

MediumOrganismsPurpose
Blood agarMost organismsGeneral purpose, shows haemolysis
Chocolate agarNeisseria, H. influenzaeHeat-lysed RBCs release factor V (NAD) + X (haemin)
MacConkey agarGram-negative enteric bacteriaLactose fermenters = pink (E. coli); non-fermenters = colourless
TCBS (Thiosulphate Citrate Bile Sucrose)Vibrio cholerae (yellow)Selective
CLED agarUrinary pathogensNon-swarming
LΓΆwenstein-Jensen (LJ)Mycobacterium tuberculosisGrowth in 4-8 weeks
Middlebrook 7H10/7H11MycobacteriaFaster growth
BACTECM. tuberculosisRadiometric/fluorescent, fastest (1-2 weeks)
Bordet-GengouB. pertussis (dewdrop colonies)Selective
Tellurite/Hoyle's mediumC. diphtheriae (black colonies)Selective
BCYE (Buffered Charcoal Yeast Extract)Legionella pneumophilaNeeds L-cysteine + iron
Sabouraud Dextrose Agar (SDA)FungiAcidic pH, antifungal antibiotics added
Fletcher's/Ellinghausen'sLeptospiraSemi-solid
Thayer-MartinNeisseria gonorrhoeaeVancomycin + colistin + nystatin
XLD / DCASalmonella, ShigellaSelective/differential

Bacterial Growth & Kinetics

Growth curve phases:
  1. Lag phase - adaptation, no division
  2. Log (exponential) phase - rapid doubling, most sensitive to antibiotics
  3. Stationary phase - growth = death, nutrients depleted
  4. Decline/Death phase - cells die
Spore formation: Only in Bacillus (aerobic) and Clostridium (anaerobic)
  • Most heat-resistant biological structure
  • Autoclave (121Β°C, 15 psi, 15 min) required for sterilisation

SECTION 2: GRAM-POSITIVE COCCI

Staphylococcus

Coagulase test - differentiates S. aureus (positive) from others (negative)

Staphylococcus aureus

  • Coagulase positive (slide + tube)
  • Beta-haemolytic on blood agar
  • Golden yellow colonies (carotenoid pigment)
  • Catalase positive
  • Protein A - binds Fc region of IgG β†’ evades opsonisation
  • MRSA - mecA gene β†’ altered PBP2a (low affinity for beta-lactams)
Diseases:
  • Skin: Folliculitis, furuncle, carbuncle, impetigo, cellulitis
  • SSSS (Scalded Skin Syndrome) - exfoliative toxin, desmoglein-1
  • Food poisoning (1-6 hrs, preformed toxin, vomiting dominant)
  • TSS (TSST-1, superantigen)
  • Pneumonia (post-influenza), bacteraemia, endocarditis
  • Osteomyelitis (most common cause in all ages)
Lab ID: Catalase +, coagulase +, beta-haemolysis, golden colonies, Mannitol fermentation (MSA), PVL for CA-MRSA

Coagulase-Negative Staphylococci (CoNS)

SpeciesDiseaseKey Feature
S. epidermidisProsthetic valve endocarditis, catheter infectionsBiofilm former, novobiocin sensitive
S. saprophyticusUTI in young sexually active womenNovobiocin resistant
S. haemolyticusEndocarditis-

Streptococcus

Classification:
  1. By haemolysis: Alpha (partial, green), Beta (complete, clear), Gamma (none)
  2. By Lancefield grouping: A, B, C, D, F, G (based on cell wall carbohydrate)

S. pyogenes (Group A Streptococcus)

  • Beta-haemolytic, Lancefield A
  • Bacitracin sensitive (A disc)
  • M protein - major virulence factor, antiphagocytic, basis of serotyping
Diseases:
  • Pharyngitis, tonsillitis
  • Impetigo (school sores)
  • Scarlet fever (SPE erythrogenic toxin, phage-encoded)
  • Necrotising fasciitis
  • Streptococcal TSS (SPE superantigen)
  • Post-streptococcal: Rheumatic fever, Post-streptococcal GN (PSGN)
PSGN: Nephritogenic strains (M types 12, 49) β†’ subepithelial "humps" on EM β†’ ↓ complement (C3) β†’ haematuria, hypertension, oedema. ASO titre elevated.
Rheumatic fever - Jones Criteria (major):
  • Carditis, Polyarthritis (migratory), Sydenham's chorea, Erythema marginatum, Subcutaneous nodules
  • CATCHES = Carditis, Arthritis, Chorea, Erythema marginatum, Subcutaneous nodules

S. agalactiae (Group B Streptococcus)

  • Beta-haemolytic, Lancefield B
  • CAMP test positive (arrowhead haemolysis with S. aureus beta-lysin)
  • Hippurate hydrolysis positive
  • Normal vaginal flora in 20-30% women
Diseases:
  • Neonatal meningitis + sepsis (most common cause)
  • Neonatal pneumonia
  • UTI in pregnant women
  • Diabetic foot infections
Prevention: GBS screening at 35-37 weeks gestation; intrapartum IV penicillin if positive

S. pneumoniae

  • Alpha-haemolytic (green on blood agar)
  • Lancet-shaped diplococci
  • Bile solubility test positive (autolysis in bile/deoxycholate)
  • Optochin sensitive
  • Inulin fermentation positive
  • Quellung reaction (capsular swelling) - for serotyping
Virulence factors:
  • Capsule - most important (prevents phagocytosis)
  • IgA protease, pneumolysin, surface proteins
Diseases:
  • Lobar pneumonia (most common cause in adults)
  • Meningitis (most common in adults + elderly)
  • Otitis media (most common in children)
  • Sinusitis
  • Most common cause of CAP at all ages

Viridans Streptococci

  • Alpha-haemolytic (partially), bile insoluble, optochin resistant
  • Normal oral flora
  • Most common cause of Subacute Bacterial Endocarditis (SBE) - S. sanguis, S. mutans, S. mitis
  • S. bovis (now S. gallolyticus) - associated with colorectal carcinoma (always colonoscopy!)
  • S. mutans - dental caries

Enterococcus (Group D)

  • Alpha or gamma haemolytic
  • Grows in 6.5% NaCl and bile esculin positive
  • Intrinsically resistant to many antibiotics
  • VRE (Vancomycin-Resistant Enterococcus) - major hospital pathogen
  • Diseases: UTI, endocarditis, biliary infections

SECTION 3: GRAM-POSITIVE BACILLI

Bacillus species (Aerobic, Spore-forming)

Bacillus anthracis

  • Bamboo-cane appearance (jointed rods)
  • Non-motile (unlike other Bacillus)
  • Non-haemolytic on blood agar
  • Capsule made of poly-D-glutamic acid (not polysaccharide)
  • Medusa head / Frosted glass colonies
  • String of pearls test (penicillin inhibition forms spheroplasts)
  • Toxins: PA + EF (oedema toxin), PA + LF (lethal toxin)
Forms of anthrax:
  • Cutaneous (most common, 95%) - malignant pustule β†’ black eschar
  • Inhalational (Woolsorter's disease) - widened mediastinum on CXR
  • GI anthrax - from ingestion of spores

Bacillus cereus

  • Food poisoning - 2 types:
    1. Emetic type (1-5 hrs, vomiting) - rice dishes (cereulide toxin, heat stable)
    2. Diarrhoeal type (8-16 hrs, diarrhoea) - meat/vegetables (enterotoxin, heat labile)

Clostridium species (Anaerobic, Spore-forming)

SpeciesSpore positionDisease
C. tetaniTerminal (drumstick)Tetanus
C. botulinumSubterminal/ovalBotulism
C. perfringensSubterminal/ovalGas gangrene, food poisoning
C. difficileSubterminalPseudomembranous colitis

C. tetani

  • Terminal spore (drumstick/tennis racket appearance)
  • Tetanospasmin (plasmid) β†’ retrograde to spinal cord β†’ blocks GABA/glycine β†’ spastic paralysis
  • Tetanolysin - haemolysin
  • Generalised tetanus: trismus β†’ risus sardonicus β†’ opisthotonus
  • Neonatal tetanus - umbilical stump infection, poor immunisation of mother

C. botulinum

  • Subterminal spore
  • Most potent biological toxin (LD50 ~1 ng/kg)
  • Blocks ACh at NMJ β†’ flaccid descending paralysis
  • Infant botulism - most common form in USA; honey β†’ spores germinate in gut
  • Home-canned food - classic adult botulism (type A, B, E)

C. perfringens

  • Stormy fermentation in litmus milk (rapid gas production)
  • Nagler reaction positive (lecithinase activity on egg-yolk agar)
  • Double zone of haemolysis on blood agar
  • Alpha toxin (lecithinase) - most important
  • Type A: gas gangrene, food poisoning
  • Type C: Necrotising enteritis (Pig-bel disease, Papua New Guinea)

C. difficile

  • Yellow, horse-manure smell colonies on CCFA medium
  • Toxin A (enterotoxin) + Toxin B (cytotoxin)
  • Glucosylates Rho GTPases β†’ cytoskeletal disruption
  • Pseudomembrane on colonoscopy (yellow plaques)
  • Associated with clindamycin, fluoroquinolones, broad-spectrum antibiotics
  • Diagnosis: Stool PCR (most sensitive), EIA for toxins
  • Treatment: Oral vancomycin or fidaxomicin (first line), bezlotoxumab (prevents recurrence)

Corynebacterium diphtheriae

  • Club-shaped (Chinese letter arrangement)
  • Albert's stain - metachromatic (volutin) granules at poles
  • Tellurite medium - black/grey colonies (reduces tellurite)
  • Elek's test - immunodiffusion to detect toxin production
  • Toxin only produced in lysogenic strains (infected by Ξ²-corynephage)
  • Toxin: ADP-ribosylates EF-2 β†’ blocks protein synthesis β†’ myocarditis, neuropathy
Clinical: Bull-neck, pseudomembrane (bleeds on removal), Schick test

Listeria monocytogenes

  • Small Gram-positive rod
  • Tumbling motility at room temperature (22Β°C), non-motile at 37Β°C
  • Cold enrichment - grows at 4Β°C (refrigerator temperature)
  • Actin rocket motility inside host cells
  • Umbrella-shaped motility in semi-solid agar
Diseases:
  • Neonatal meningitis + sepsis (along with GBS)
  • Meningitis in elderly + immunocompromised
  • Granulomatosis infantiseptica (disseminated in neonates)
  • Food-borne (soft cheeses, deli meats, raw vegetables)
  • Treatment: Ampicillin + Gentamicin (NOT cephalosporins - intrinsically resistant)

SECTION 4: GRAM-NEGATIVE COCCI

Neisseria

N. meningitidis

  • Diplococci (kidney-shaped pairs), intracellular in CSF
  • Requires chocolate agar or blood agar with COβ‚‚
  • Polysaccharide capsule - key virulence factor (13 serogroups: A, B, C, W, Y most important)
  • Ferments glucose + maltose (distinguishes from N. gonorrhoeae)
  • IgA protease
Diseases:
  • Meningitis (most common bacterial meningitis in meningitis belt Africa)
  • Meningococcaemia with Waterhouse-Friderichsen syndrome (bilateral adrenal haemorrhage, purpuric rash, DIC)
  • Petechiae/purpura is the hallmark
  • Terminal complement deficiency (C5-C9) β†’ recurrent Neisseria infections
Treatment: Penicillin G (IV), ceftriaxone Prophylaxis for contacts: Rifampicin or Ciprofloxacin or Ceftriaxone (single dose)

N. gonorrhoeae

  • No polysaccharide capsule
  • Ferments glucose only (not maltose)
  • Thayer-Martin medium (chocolate agar + antibiotics)
  • Pili - type IV, antigenic variation (pilE gene)
  • Protein II (Opa proteins) - mediate attachment to epithelial cells
  • IgA protease - cleaves secretory IgA
  • Beta-lactamase (plasmid) - penicillin resistance
Diseases:
  • Urethritis, cervicitis
  • PID, salpingitis (Fitz-Hugh-Curtis syndrome - perihepatitis)
  • Ophthalmia neonatorum (treated with erythromycin eye ointment)
  • Disseminated gonococcal infection (DGI): septic arthritis, skin lesions, tenosynovitis
  • Treatment: Ceftriaxone IM (DOC now due to widespread resistance)

SECTION 5: GRAM-NEGATIVE BACILLI

Enterobacteriaceae (Lactose fermenters vs Non-fermenters)

MacConkey agar:
  • Pink colonies (lactose fermenters): E. coli, Klebsiella, Enterobacter, Citrobacter
  • Colourless (non-fermenters): Salmonella, Shigella, Proteus

Escherichia coli

Normal colonic flora but pathogenic strains:
StrainToxin/MechanismDisease
ETECLT (↑cAMP) + ST (↑cGMP)Traveller's diarrhoea, infant diarrhoea
EPECA/E lesion (attaching-effacing), no toxinInfant diarrhoea (developing countries)
EHEC (STEC)Shiga-like toxin (verotoxin), O157:H7Bloody diarrhoea β†’ HUS
EIECIntracellular invasion (like Shigella)Dysentery (bloody diarrhoea, fever)
EAECAggregative adherence, ST-likePersistent diarrhoea in children
DAECDiffuse adherenceUTI, mild diarrhoea
Other E. coli diseases:
  • UTI (most common cause) - fimbriae, P pili (uropathogenic)
  • Neonatal meningitis (K1 capsular antigen)
  • Neonatal meningitis: E. coli K1 + GBS = top 2 causes

Klebsiella

  • Large mucoid colonies, thick capsule (mucoviscosity)
  • Currant jelly sputum (haemorrhagic, mucoid)
  • FriedlΓ€nder's pneumonia - upper lobe, alcohol/diabetes
  • UTI (hospital-acquired, catheter)
  • K. granulomatis (formerly Calymmatobacterium) β†’ Granuloma inguinale (Donovanosis)
    • Donovan bodies in macrophages

Salmonella

Salmonella typhi (Typhoid fever)

Pathogenesis:
  • Ingested β†’ invades Peyer's patches (ileum) β†’ M cells β†’ macrophages β†’ blood
  • Bacteraemia β†’ seeded to liver, spleen, bone marrow, Peyer's patches
Clinical (weeks):
  • Week 1: Fever, step-ladder pattern, headache, relative bradycardia
  • Week 2: Rose spots (anterior chest), splenomegaly, hepatomegaly
  • Week 3: Complications - intestinal haemorrhage/perforation, myocarditis
  • Week 4: Resolution
Lab:
  • Week 1: Blood culture (most sensitive early)
  • Week 2-3: Stool + urine culture
  • Widal test: O agglutinins (active disease), H agglutinins (past infection/vaccination)
    • Significant: O titre β‰₯1:160; H titre β‰₯1:320
Treatment: Azithromycin (first line outpatient), Ceftriaxone (severe), Ciprofloxacin (if sensitive) Carrier state: Bile β†’ faecal carrier (chronic carriage in gallbladder)

Non-typhoidal Salmonella

  • Food poisoning (poultry, eggs)
  • Gastroenteritis (self-limiting, 2-3 days)
  • Bacteraemia in sickle cell disease (Salmonella osteomyelitis)

Shigella

4 species by decreasing severity:
  • S. dysenteriae (most severe, Shiga toxin, HUS) > S. flexneri > S. boydii > S. sonnei (mildest, most common in developed world)
Pathogenesis:
  • Very small inoculum (10-100 organisms)
  • Invades colonic mucosa β†’ intracellular spread via actin rockets
  • Causes dysentery (bloody diarrhoea + mucus + pus)
Lab: Non-lactose fermenter, non-motile, non-gas producing, Hβ‚‚S negative Treatment: Azithromycin / Ciprofloxacin (antibiotics always indicated - reduces duration)

Vibrio

Vibrio cholerae

  • Comma-shaped, oxidase positive
  • TCBS agar - yellow colonies (sucrose fermenter)
  • Serotype O1 (classic + El Tor biotypes) and O139 cause epidemics
  • Darting motility (shooting star appearance)
  • Dark-field microscopy - characteristic motility
  • Toxin: Cholera toxin (CT) - phage-encoded (CTXΟ†), ↑cAMP
  • Rice-water diarrhoea, severe dehydration, "washerwoman's hands"
  • Treatment: Oral rehydration salts (primary); Doxycycline (antibiotic shortens duration)

V. parahaemolyticus

  • Seafood consumption (raw shellfish, crabs)
  • Watery or bloody diarrhoea
  • Blue-green colonies on TCBS (non-sucrose fermenter)

V. vulnificus

  • Most virulent Vibrio
  • Necrotising soft tissue infections in coastal areas
  • Liver disease patients β†’ fatal septicaemia from raw oysters

Campylobacter

Campylobacter jejuni

  • Most common bacterial cause of food-borne diarrhoea globally
  • S-shaped / gull-wing-shaped rods
  • Microaerophilic (5% Oβ‚‚)
  • 42Β°C optimal growth temperature (selective advantage)
  • Darting motility (corkscrew)
  • Campy-BAP medium (blood agar + antibiotics, 42Β°C)
Diseases:
  • Bloody diarrhoea (invasive)
  • Post-infectious complications:
    • Guillain-BarrΓ© syndrome (GBS) - molecular mimicry, ganglioside antibodies
    • Reactive arthritis
    • C. jejuni serotype O:19 most associated with GBS
Treatment: Azithromycin or Erythromycin

Helicobacter pylori

  • Spiral-shaped, microaerophilic
  • Urease positive (most important virulence factor - produces ammonia, neutralises acid)
  • CLO test (Campylobacter-like organism test) - biopsy urease test
Virulence factors:
  • Urease, flagella, adhesins
  • CagA (cytotoxin-associated gene A) - associated with gastric cancer + peptic ulcer
  • VacA (vacuolating cytotoxin) - mucosal damage
Diseases:
  • Peptic ulcer disease (duodenal 95%, gastric 70%)
  • Chronic gastritis (type B antral gastritis)
  • Gastric adenocarcinoma (IARC Group 1 carcinogen)
  • MALT lymphoma (eradication alone can cure early MALT lymphoma)
Diagnosis:
  • Urea breath test (UBT) - best non-invasive test, best for test of cure
  • Stool antigen test (non-invasive)
  • Serology (IgG ELISA) - cannot distinguish active vs past
  • Endoscopic biopsy: CLO test + histology + culture (most specific)
Treatment (Triple therapy):
  • PPI + Clarithromycin + Amoxicillin (or Metronidazole) for 14 days

Pseudomonas aeruginosa

  • Oxidase positive, non-fermenter
  • Blue-green pigment (pyocyanin) + fluorescent pigment (pyoverdin)
  • Grape-like/fruity odour (2-aminoacetophenone)
  • Grows at 42Β°C (selective advantage)
  • Mucoid strains in cystic fibrosis (alginate capsule)
Virulence: Exotoxin A (blocks EF-2), Exoenzyme S, alkaline protease, phospholipase C, pyocyanin (damages cilia, generates free radicals)
Diseases:
  • Nosocomial pneumonia (ventilator-associated)
  • Burn wound infections
  • Malignant otitis externa (diabetics, elderly)
  • Cystic fibrosis lung infections
  • Hot tub folliculitis
  • UTI (catheterised patients)
  • Ecthyma gangrenosum (black necrotic skin lesion in immunocompromised)
Treatment: Piperacillin-tazobactam, Carbapenems, Aminoglycosides, Ciprofloxacin (anti-pseudomonal)

Haemophilus influenzae

  • Small pleomorphic Gram-negative coccobacillus
  • Requires Factor X (haemin) + Factor V (NAD) for growth
  • Chocolate agar (blood heated to 80Β°C releases X and V factors)
  • Satellitism around Staph aureus colonies on blood agar
  • Type b capsule (polyribose ribitol phosphate) - most virulent, vaccine-preventable
Diseases:
  • Meningitis (before Hib vaccine - most common in children)
  • Epiglottitis (type b) - "thumb sign" on lateral neck X-ray
  • Pneumonia (non-typeable strains, adults with COPD)
  • Otitis media, sinusitis
  • Conjunctivitis (non-typeable)
Treatment: Ceftriaxone (meningitis), Amoxicillin-clavulanate (URTI)

Bordetella pertussis

  • Small Gram-negative coccobacillus
  • Bordet-Gengou medium (potato blood glycerol agar) - mercury drop colonies
  • Filamentous haemagglutinin (FHA) - major adhesin
  • Pertussis toxin (PT), tracheal cytotoxin, adenylate cyclase toxin
Clinical stages (whooping cough):
  1. Catarrhal phase (1-2 weeks) - most infectious, mild cold symptoms
  2. Paroxysmal phase (2-6 weeks) - paroxysmal cough + inspiratory whoop + post-tussive vomiting
  3. Convalescent phase (weeks-months) - gradual recovery
Lab: Lymphocytosis (absolute), PT causes lymphocytes to stay in blood Treatment: Azithromycin (drug of choice), Erythromycin Prevention: DTaP (children), Tdap (adults, especially pregnant women)

Legionella pneumophila

  • BCYE agar (L-cysteine + iron required)
  • Cannot be seen on Gram stain easily (takes up safranin poorly)
  • Dieterle silver stain used for tissue
  • Intracellular pathogen (multiplies in macrophages + protozoa)
  • Source: Air conditioning cooling towers, water heaters, hospital water
Clinical (Legionnaires' disease):
  • Severe pneumonia (especially in middle-aged men, smokers, immunocompromised)
  • Relative bradycardia, hyponatraemia, elevated LFTs, diarrhoea, confusion
  • "Pontiac fever" = mild flu-like illness (same organism, no pneumonia)
Diagnosis:
  • Urinary antigen test (most rapid, detects serogroup 1)
  • Culture on BCYE (gold standard, slow)
  • DFA (direct fluorescent antibody)
Treatment: Azithromycin or Fluoroquinolones (macrolides or quinolones, NOT beta-lactams)

Brucella

  • Obligate intracellular (facultative)
  • Gram-negative coccobacillus
  • Zoonosis - from cattle (B. abortus), goat/sheep (B. melitensis - most virulent), pigs (B. suis), dogs (B. canis)
  • Transmission: unpasteurised milk/cheese, contact with infected animals
Clinical: Undulant fever (fever spikes every 2-3 days), hepatosplenomegaly, lymphadenopathy, arthritis, orchitis
Lab: Blood culture (prolonged incubation 4-6 weeks), serology (Wright's agglutination test) Treatment: Doxycycline + Rifampicin (6 weeks) or Doxycycline + Streptomycin

Yersinia

Yersinia pestis (Plague)

  • Gram-negative coccobacillus, bipolar staining (safety-pin appearance) with Wayson's stain
  • Reservoir: Rodents; Vector: Rat flea (Xenopsylla cheopis)
  • Forms: Bubonic (most common, bubo = inguinal lymph node), Pneumonic (most dangerous, droplet spread), Septicaemic

Y. enterocolitica

  • Cold-enrichment, grows at 4Β°C
  • Mimics acute appendicitis (mesenteric lymphadenitis)
  • Bloody diarrhoea, fever

Francisella tularensis (Tularaemia)

  • Most infectious bacterium (10 organisms cause disease)
  • Gram-negative coccobacillus
  • Reservoir: Rabbits, rodents; Vector: Ticks, deer flies
  • Transmission: tick bite, handling infected animals, inhalation
  • Requires cysteine for growth
  • Forms: Ulceroglandular (most common), Pneumonic, Oculoglandular, Typhoidal

SECTION 6: ANAEROBIC BACTERIA

Bacteroides fragilis

  • Most common anaerobe in human colon
  • Polysaccharide capsule (only anaerobe with a capsule)
  • Metronidazole - drug of choice
  • Important in intra-abdominal infections, peritonitis

Fusobacterium

  • Long pointed rods
  • Associated with Lemierre's syndrome (septic thrombophlebitis of internal jugular vein after pharyngitis)
  • Also in periodontal disease (along with Treponema - ANUG)

SECTION 7: SPIROCHETES

Treponema pallidum (Syphilis)

  • Cannot be cultured on artificial media
  • Too thin for Gram stain
  • Dark-field microscopy (corkscrew motility)
  • Silver stain (Warthin-Starry, Levaditi) for tissue sections
Stages of syphilis:
StageFeaturesSerology
PrimaryPainless chancre (indurated, clean base), inguinal lymphadenopathyVDRL may be negative early
SecondaryMaculopapular rash (palms + soles), condylomata lata, mucosal patches, alopecia, feverVDRL strongly positive
LatentAsymptomatic (early <1yr, late >1yr)Positive
TertiaryGummas, CV syphilis (aortic regurgitation, aortic aneurysm), neurosyphilisVDRL may be negative
Serological tests:
  • Non-treponemal (screening): VDRL, RPR - become negative after treatment (used for monitoring)
  • Treponemal (confirmatory): TPHA, FTA-ABS, TPPA - remain positive lifelong
  • Biological false positives (VDRL): SLE, antiphospholipid syndrome, malaria, pregnancy, TB, infectious mononucleosis
Neurosyphilis: CSF-VDRL (specific but insensitive), treat with IV penicillin G
Congenital syphilis:
  • Hutchinson's teeth, interstitial keratitis, sensorineural deafness (Hutchinson's triad)
  • Saddle nose, sabre tibia, Clutton's joints
Treatment: Benzathine penicillin G (primary, secondary, early latent)

Leptospira (Leptospirosis)

  • Hooked ends (question mark appearance)
  • Fletcher's medium (semi-solid)
  • Dark-field microscopy
Transmission: Contact with urine of infected rodents/animals (Weil's disease from rats) Weil's disease (severe leptospirosis): Jaundice + renal failure + haemorrhage
Treatment: Penicillin G (severe), Doxycycline (mild/prophylaxis)

Borrelia

Borrelia burgdorferi (Lyme disease)

  • Vector: Ixodes tick (deer tick)
  • Giemsa stain, Barbour-Stoenner-Kelly (BSK) medium
Stages:
  1. Stage 1: Erythema migrans (bulls-eye rash) at tick bite site
  2. Stage 2: Dissemination - Bell's palsy, meningitis, carditis (heart block)
  3. Stage 3: Arthritis (large joints, esp. knee), chronic neurological (Lyme encephalopathy)
Treatment: Doxycycline (stages 1-2), Ceftriaxone (stage 3/neurological)

Borrelia recurrentis (Relapsing fever)

  • Vector: Body louse (epidemic relapsing fever)
  • Giemsa stain during febrile episodes
  • Antigenic variation of OspC protein β†’ relapsing fever

SECTION 8: INTRACELLULAR BACTERIA

Rickettsia

Obligate intracellular, Gram-negative Arthropod vectors (tick, mite, louse, flea) Giemsa stain, Weil-Felix reaction (agglutination with Proteus strains)
DiseaseOrganismVectorWeil-Felix
Rocky Mountain Spotted FeverR. rickettsiiTickOX-2, OX-19
Epidemic typhusR. prowazekiiBody louseOX-19
Endemic (murine) typhusR. typhiRat fleaOX-19
Scrub typhusOrientia tsutsugamushiTrombiculid miteOX-K
Q feverCoxiella burnetiiInhalation (no vector)Negative
Key features:
  • Scrub typhus - eschar at bite site, characteristic; Indian Ocean islands, Asia
  • Q fever - atypical pneumonia + hepatitis + no rash + no vector; phase I/II antigen; Weil-Felix negative
  • Epidemic typhus - louse-borne, war/crowded conditions, Brill-Zinsser disease (recrudescence)
  • RMSF - petechial rash starts on wrists and ankles β†’ spreads centrally
Treatment: All rickettsial diseases β†’ Doxycycline (drug of choice)

Chlamydia

Obligate intracellular, Gram-negative (no peptidoglycan in cell wall) Two forms:
  • Elementary body (EB) - infectious, metabolically inert, extracellular
  • Reticulate body (RB) - replicating, intracellular, metabolically active
Staining: Giemsa (mauve intracytoplasmic inclusions)

Chlamydia trachomatis (serovars)

SerovarsDisease
A, B, Ba, CTrachoma (leading cause of infectious blindness)
D-KUrethritis, cervicitis, PID, epididymitis, neonatal conjunctivitis, neonatal pneumonia
L1, L2, L3Lymphogranuloma venereum (LGV)
Trachoma: Follicular conjunctivitis β†’ pannus formation β†’ scarring β†’ entropion β†’ blindness LGV: Painless genital ulcer β†’ inguinal lymphadenopathy (buboes, "groove sign")

C. pneumoniae (TWAR strain)

  • Atypical pneumonia (mild, walking pneumonia)
  • Associated with atherosclerosis

C. psittaci

  • Psittacosis/Ornithosis - from birds (parrots, pigeons)
  • Atypical pneumonia + systemic features
Treatment: Doxycycline or Azithromycin (all Chlamydia)
  • Trachoma: Azithromycin single dose (SAFE strategy)

Mycoplasma

No cell wall β†’ not seen on Gram stain, resistant to penicillin/beta-lactams

Mycoplasma pneumoniae

  • Cold agglutinins (IgM against I antigen on RBCs) - positive in ~50%
  • Causes autoimmune haemolytic anaemia
  • Atypical pneumonia ("walking pneumonia")
  • Eaton agent - grows on Eaton's medium (SP4 medium)
  • Fried-egg colonies on Eaton's medium
Clinical: Gradual onset fever, dry cough, bilateral patchy infiltrates Complications: Stevens-Johnson syndrome, encephalitis, haemolytic anaemia, erythema multiforme
Treatment: Azithromycin or Doxycycline (NOT penicillin)

Mycoplasma genitalium

  • NGU (non-gonococcal urethritis)
  • Emerging resistance to azithromycin; moxifloxacin used

Ureaplasma urealyticum

  • NGU, splits urea
  • Associated with premature delivery

SECTION 9: MYCOBACTERIUM

Mycobacterium tuberculosis

Cell wall: Rich in mycolic acid (wax D) β†’ acid-fast (retain carbol fuchsin after acid-alcohol decolourisation)
Growth characteristics:
  • Strict aerobe
  • Slow growth (generation time 16-20 hrs)
  • LJ medium (eggs + glycerol + malachite green) - 4-8 weeks
  • Buff, rough, dry, crumbly colonies
Virulence factors:
  • Cord factor (Trehalose 6,6'-dimycolate) - inhibits PMN migration, toxic to mitochondria, causes serpentine cord growth
  • Wax D (mycolic acid) - acid-fastness, adjuvant property
  • Sulfatides - inhibit phagolysosome fusion
  • Lipoarabinomannan (LAM) - scavenges free radicals, inhibits T cell activation
Pathogenesis:
  • Droplet nuclei (<5 ΞΌm) β†’ alveoli β†’ ingested by macrophages (but resists killing)
  • Primary complex (Ghon focus = parenchymal lesion + hilar lymph node = Ranke complex)
  • Hypersensitivity (Type IV, delayed, Th1-mediated) = tuberculin sensitivity
  • Caseation necrosis, granuloma (epithelioid cells, Langhan's giant cells)
Diagnosis:
  • Sputum AFB smear (ZN stain, most rapid, but needs 5,000-10,000 bacilli/mL)
  • Culture on LJ medium (gold standard, but slow)
  • BACTEC/MGIT (liquid culture, fastest - 1-3 weeks)
  • Xpert MTB/RIF (PCR-based, detects TB + rifampicin resistance simultaneously, 2 hours) - WHO recommended first test
  • Tuberculin skin test (Mantoux) - inject 5TU PPD intradermally, read at 48-72 hrs
    • β‰₯5 mm: HIV, recent contact, fibrotic lesion on CXR
    • β‰₯10 mm: High-risk groups (healthcare workers, immigrants, homeless)
    • β‰₯15 mm: No risk factors
Tuberculin false positives: BCG vaccination, NTM (non-tuberculous mycobacteria) Tuberculin false negatives: Immunocompromised (HIV, malnutrition, old age), miliary TB, sarcoidosis
Treatment (DOTS):
  • Intensive phase (2 months): HRZE (Isoniazid + Rifampicin + Pyrazinamide + Ethambutol)
  • Continuation phase (4 months): HR (Isoniazid + Rifampicin)
Drug adverse effects:
DrugAdverse Effects
Isoniazid (H)Peripheral neuropathy (B6), hepatitis, drug lupus, seizures
Rifampicin (R)Orange secretions, hepatitis, flu syndrome, enzyme inducer
Pyrazinamide (Z)Hyperuricaemia, hepatotoxicity
Ethambutol (E)Optic neuritis (retrobulbar, colour blindness), avoid in children
Streptomycin (S)Ototoxicity (vestibular > cochlear), nephrotoxicity

Mycobacterium leprae (Leprosy)

  • Cannot be cultured on artificial media (like T. pallidum)
  • Grown in armadillo footpads (in vivo)
  • Acid-fast (ZN stain, also Wade-Fite stain)
  • Fite-Faraco stain used in tissue sections
Ridley-Jopling classification:
TypeImmunityBacilliLepromin testFeatures
Tuberculoid (TT)High (Th1)Few (paucibacillary)Positive1-2 anaesthetic, hypopigmented lesions; thick nerves
Borderline tuberculoid (BT)↑Few+-
Mid-borderline (BB)IntermediateIntermediateΒ±Unstable
Borderline lepromatous (BL)↓Many--
Lepromatous (LL)Low (Th2)Many (multibacillary)NegativeDiffuse infiltration, leonine facies, madarosis, nerve damage bilateral
Lepromin test (Mitsuda test):
  • Tests cell-mediated immunity, not diagnosis
  • Positive = TT (good prognosis), Negative = LL (poor prognosis)
Complications:
  • Type 1 reaction (reversal reaction) - upgrading or downgrading, treat with prednisolone
  • Type 2 reaction (ENL - Erythema Nodosum Leprosum) - immune complex, treat with thalidomide/prednisolone
Treatment (WHO regimen):
  • Paucibacillary (PB): Rifampicin (monthly supervised) + Dapsone (daily) Γ— 6 months
  • Multibacillary (MB): Rifampicin + Clofazimine (monthly supervised) + Dapsone + Clofazimine (daily) Γ— 12 months

Non-Tuberculous Mycobacteria (NTM)

OrganismDisease
M. avium-intracellulare (MAC)Disseminated infection in AIDS (CD4 <50)
M. kansasiiPulmonary TB-like disease
M. marinumSwimming pool granuloma, fish tank granuloma
M. ulceransBuruli ulcer (painless ulcers)
M. fortuitum, M. chelonae, M. abscessusRapidly growing, post-injection abscesses, LASIK keratitis
M. scrofulaceumCervical lymphadenitis in children

SECTION 10: VIROLOGY

DNA Viruses (mnemonic: HHAPPPY)

Herpesvirus, Hepadnavirus, Adenovirus, Papillomavirus, Poxvirus, Parvovirus, Yest (fungus, not virus!)

Herpes Viruses (HHV 1-8)

VirusPrimary DiseaseLatency SiteReactivation
HSV-1 (HHV-1)Oral herpes, gingivostomatitisTrigeminal ganglionCold sores, herpes labialis
HSV-2 (HHV-2)Genital herpesSacral ganglionGenital recurrences
VZV (HHV-3)ChickenpoxDorsal root/cranial gangliaHerpes zoster (shingles)
EBV (HHV-4)Infectious mononucleosis, Burkitt's lymphomaB lymphocytesLymphomas in immunocompromised
CMV (HHV-5)Congenital CMV, mono-like illnessMonocytes/macrophagesRetinitis, pneumonitis, colitis in AIDS
HHV-6Roseola infantum (exanthem subitum)T lymphocytesEncephalitis in transplant
HHV-7Roseola, pityriasis roseaT lymphocytes-
HHV-8 (KSHV)Kaposi's sarcomaB lymphocytesKaposi's sarcoma in AIDS/transplant
EBV (Infectious Mononucleosis):
  • Fever + pharyngitis + lymphadenopathy + splenomegaly
  • Monospot test (heterophile antibodies) - positive
  • Atypical lymphocytes (Downey cells) on peripheral smear
  • Ampicillin/amoxicillin β†’ maculopapular rash in EBV (avoid!)
  • Associated: Burkitt's lymphoma, Nasopharyngeal carcinoma, Post-transplant lymphoproliferative disorder, CNS lymphoma in AIDS
CMV:
  • Most common congenital viral infection causing hearing loss
  • Periventricular calcifications (congenital CMV) vs cortical calcifications (Toxoplasma)
  • Owl-eye inclusions in infected cells
  • CMV retinitis (AIDS, CD4 <50) - "pizza pie" or "ketchup & cheese" appearance
VZV:
  • Chickenpox: Centripetal distribution, "dew drop on rose petal" vesicles, all stages simultaneously
  • Herpes zoster: Dermatomal, painful, unilateral; Ramsay Hunt syndrome (VII nerve + ear)
  • Tzanck smear - multinucleated giant cells (both HSV and VZV)
  • Treatment: Aciclovir (all herpesviruses), Valaciclovir (higher bioavailability)

Hepatitis Viruses

VirusTypeTransmissionChronicityKey Feature
HAVRNA (Picorna)Faeco-oralNoneSelf-limiting, no carrier
HBVDNA (Hepadna)Blood, sexual, vertical5-10% adults, 90% neonatesDane particle, HBsAg, HBeAg, anti-HBc
HCVRNA (Flavi)Blood (IVDU, transfusion)70-80%Most common cause of chronic liver disease in West
HDVRNA (delta)Blood, sexualOnly with HBVSatellite virus, needs HBsAg
HEVRNA (Hepevirus)Faeco-oralNoneHigh mortality in pregnancy (20-25%)
HBV markers:
MarkerMeaning
HBsAgActive infection (surface antigen)
Anti-HBsRecovery/immunity (vaccination)
HBeAgHigh infectivity, active replication
Anti-HBeLow infectivity, seroconversion
Anti-HBc IgMAcute HBV (also present in window period)
Anti-HBc IgGPast infection or chronic
HBV DNAGold standard for viral replication
Window period: HBsAg gone, Anti-HBs not yet appeared β†’ only Anti-HBc IgM positive
Treatment HBV: Tenofovir or Entecavir (first line) Treatment HCV: Direct-acting antivirals (DAAs) - Sofosbuvir + Ledipasvir or Sofosbuvir + Velpatasvir (~95% cure rate)

HIV

Classification: Lentivirus (Retrovirus family), RNA virus, reverse transcriptase Receptor: CD4 + CCR5/CXCR4 (co-receptors)
  • CCR5 - used by macrophage-tropic strains (M-tropic, R5 strains) - early infection
  • CXCR4 - used by T-cell tropic strains (T-tropic, X4 strains) - late disease
  • Delta 32 mutation in CCR5 β†’ resistance to HIV (homozygous protective)
CD4 count and infections:
CD4 countOpportunistic infections
<500Candida, TB, HSV, HZV
<200PCP (P. jirovecii), Toxoplasma, Cryptosporidium, Microsporidium
<100Cryptococcus, Bartonella
<50CMV (retinitis), MAC (disseminated)
Diagnosis:
  • ELISA (4th generation - detects IgG + p24 antigen) - screening
  • Western blot - confirmatory (bands at gp120, gp41, p24)
  • HIV RNA PCR - viral load (monitors treatment), used in neonates (maternal antibodies confound serology for 18 months)
Treatment (ART): HAART - start in ALL patients regardless of CD4 count
  • Standard first-line: 2 NRTIs + 1 INSTI (e.g., TDF + FTC + Dolutegravir)
Drug classes:
ClassExamplesKey Side Effect
NRTIsZidovudine, Lamivudine, Tenofovir, EmtricitabineLactic acidosis, lipodystrophy; AZT β†’ anaemia
NNRTIsEfavirenz, NevirapineCNS effects (efavirenz), hepatotoxicity (nevirapine)
PIsLopinavir, Ritonavir, AtazanavirLipodystrophy, GI, jaundice (atazanavir)
INSTIsDolutegravir, RaltegravirWell tolerated, weight gain
Fusion inhibitorEnfuvirtideSC injection, injection site reactions
CCR5 antagonistMaravirocOnly for R5 strains (tropism testing needed)

Respiratory Viruses

VirusDiseaseKey Facts
Influenza A, BFlu, pneumoniaHaemagglutinin (HA) + Neuraminidase (NA) surface antigens
Respiratory Syncytial Virus (RSV)Bronchiolitis (infants), pneumoniaMost common cause of bronchiolitis in infants <2 years
ParainfluenzaCroup (laryngotracheobronchitis), URISteeple sign on X-ray
AdenovirusURI, pharyngoconjunctival fever, military recruitsDNA virus
RhinovirusCommon coldPicornavirus, most common cause
CoronavirusSARS, MERS, COVID-19Spike protein, ACE2 receptor
Influenza:
  • Antigenic drift (minor changes in HA/NA, point mutations) β†’ seasonal epidemics
  • Antigenic shift (major reassortment of genome segments) β†’ pandemics
  • Reassortment between human + animal (avian/swine) strains
  • Treatment: Oseltamivir (Tamiflu) - neuraminidase inhibitor, within 48 hours of symptoms
  • Amantadine/Rimantadine (M2 inhibitors) - only influenza A, widespread resistance

Childhood Exanthems

DiseaseVirusRashOther features
MeaslesParamyxovirus (Morbillivirus)Maculopapular, centrifugal, appears 4th day of feverKoplik spots (pathognomonic, before rash)
RubellaTogavirusMaculopapular, face→trunk, finePost-auricular lymphadenopathy, forchheimer spots, congenital rubella
ChickenpoxVZVVesicular, centripetal, all stages simultaneously"Dew drop on rose petal"
Roseola infantumHHV-6Rash after fever subsidesHigh fever β†’ febrile seizures β†’ rash
Erythema infectiosumParvovirus B19Slapped cheek β†’ lacy rashAplastic crisis in sickle cell, hydrops fetalis
Hand-foot-mouthCoxsackievirus A16Vesicles on hands, feet, mouthEnterovirus
Measles complications: Pneumonia, encephalitis, SSPE (Subacute sclerosing panencephalitis) - years later
Congenital rubella syndrome (CRS):
  • Cataracts, patent ductus arteriosus (PDA), sensorineural deafness
  • "Blueberry muffin" baby (dermal haematopoiesis)
  • Prevention: MMR vaccine (live attenuated, avoid in pregnancy)

Enteroviruses (Picornaviridae)

  • Poliovirus, Coxsackievirus, Echovirus, Enterovirus
  • Faeco-oral transmission, replicate in intestine
  • Poliovirus: Anterior horn cells β†’ lower motor neurone lesion β†’ flaccid paralysis
    • OPV (oral, live attenuated) vs IPV (injectable, killed)
    • Vaccine-associated paralytic poliomyelitis (VAPP) - rare, only with OPV
  • Coxsackievirus A16 - Hand-foot-mouth disease, herpangina
  • Coxsackievirus B - Myocarditis (most common cause of viral myocarditis), pleurodynia (Bornholm disease), neonatal sepsis

SECTION 11: MYCOLOGY (FUNGI)

Classification

Superficial: Malassezia furfur (tinea versicolor), Trichosporon (white piedra) Cutaneous (Dermatophytes): Trichophyton, Microsporum, Epidermophyton β†’ tinea (ringworm) Subcutaneous: Sporothrix schenckii (sporotrichosis), Madurella (Madura foot) Systemic: Histoplasma, Coccidioides, Blastomyces, Paracoccidioides Opportunistic: Candida, Cryptococcus, Aspergillus, Mucor/Rhizopus, Pneumocystis

Key Fungi

Candida albicans

  • Dimorphic - yeast at 37Β°C, hyphae/pseudohyphae in tissue
  • Germ tube test (positive) - forms germ tubes in serum at 37Β°C
  • Chlamydoconidia - on cornmeal agar
  • Thrush (oral, oesophageal), vulvovaginitis, diaper rash, systemic candidiasis
  • Risk factors: antibiotics, diabetes, immunosuppression, catheters
  • Treatment: Fluconazole (superficial), Amphotericin B or Echinocandins (systemic)

Cryptococcus neoformans

  • Encapsulated yeast, India ink - halo capsule
  • Mucicarmine positive capsule (pink staining)
  • Urease positive, phenol oxidase positive (melanin production)
  • Source: Pigeon droppings (dried pigeon faeces)
  • Meningitis in AIDS (CD4 <100) - "soap bubble" lesions in basal ganglia
  • India ink - direct CSF exam
  • Serum/CSF cryptococcal antigen (CrAg) - most sensitive
  • Treatment: Amphotericin B + Flucytosine (induction) β†’ Fluconazole (consolidation/maintenance)

Aspergillus fumigatus

  • Septate hyphae with acute angle branching (45Β°)
  • Conidiophore with vesicle and phialides (fruiting body)
  • Source: Decaying vegetation, construction sites
  • Diseases:
    • Allergic bronchopulmonary aspergillosis (ABPA) - asthma/CF patients, IgE↑, central bronchiectasis
    • Aspergilloma ("fungus ball") - in pre-existing cavity (old TB), aerial hyphae on CT
    • Invasive aspergillosis - immunocompromised (neutropenic), "halo sign" on CT chest
  • Treatment: Voriconazole (first line for invasive), Amphotericin B, Caspofungin

Mucor / Rhizopus (Zygomycetes/Mucormycosis)

  • Non-septate (aseptate/pauci-septate) hyphae with right-angle (90Β°) branching
  • Ribbon-like hyphae
  • Risk factors: Diabetic ketoacidosis (DKA), iron overload, deferoxamine treatment, neutropenia
  • Rhinocerebral mucormycosis (most common form) - black eschar on nasal turbinates, invades orbit
  • Treatment: Amphotericin B (first line), surgical debridement

Pneumocystis jirovecii

  • NOT a true fungus (originally thought to be a protozoan, reclassified)
  • Cannot be cultured in standard media
  • GMS (Gomori methenamine silver) stain - black cysts with "helmet" or "crushed ping-pong ball" appearance
  • Causes PCP (Pneumocystis pneumonia) in AIDS (CD4 <200)
  • CXR: bilateral interstitial infiltrates ("ground glass"), perihilar
  • LDH elevated (marker of severity)
  • Treatment: Co-trimoxazole (TMP-SMX) - first line, also prophylaxis when CD4 <200
  • Alternatives: Pentamidine, Atovaquone, Primaquine + Clindamycin

Sporothrix schenckii

  • Dimorphic - mould in environment, yeast in tissue
  • Rose thorn injury (florists, gardeners)
  • Lymphocutaneous sporotrichosis - nodules along lymphatics
  • Treatment: Itraconazole (potassium iodide for cutaneous)

Histoplasma capsulatum

  • Dimorphic - mould (25Β°C), yeast (37Β°C, intracellular in macrophages)
  • Ohio-Mississippi River valley (bird + bat droppings)
  • Resembles leishmaniasis on tissue (small intracellular yeasts)
  • Treatment: Itraconazole (mild), Amphotericin B (severe)

Antifungal Drugs

DrugMechanismSpectrumKey Side Effect
Amphotericin BBinds ergosterol β†’ pore formationBroad (Candida, Aspergillus, Cryptococcus, Mucor)Nephrotoxicity, hypokalaemia, infusion reactions
Azoles (Fluconazole, Itraconazole, Voriconazole)Inhibit ergosterol synthesis (CYP51/14Ξ±-demethylase)Varies by agentHepatotoxicity, drug interactions (CYP450)
Echinocandins (Caspofungin, Micafungin)Inhibit Ξ²-glucan synthase β†’ disrupts cell wallCandida, Aspergillus (NOT Cryptococcus)Minimal, well tolerated
Flucytosine (5-FC)Converted to 5-FU β†’ inhibits thymidylate synthaseCryptococcus, CandidaBone marrow suppression
GriseofulvinDisrupts microtubules β†’ inhibits mitosisDermatophytes onlyTeratogenic, liver induction
TerbinafineInhibits squalene epoxidaseDermatophytesHepatotoxicity

SECTION 12: PARASITOLOGY

Malaria

Plasmodium species:
SpeciesRBC affectedFever cycleComplicationsUnique features
P. falciparumAll RBCsIrregular/tertian (36-48 hr)Cerebral malaria, ARDS, blackwater feverMaurer's clefts, accolΓ© forms, multiple rings/RBC
P. vivaxYoung (reticulocytes)Benign tertian (48 hr)Rupture spleenSchΓΌffner's dots, hypnozoites (liver relapse)
P. ovaleYoungBenign tertian (48 hr)MildSchΓΌffner's dots, oval RBCs, hypnozoites
P. malariaeOld RBCsQuartan (72 hr)Nephrotic syndrome (immune complex)Band-form trophozoites
P. knowlesiAllQuotidian (24 hr)SevereZoonosis (macaques), SE Asia
Diagnosis:
  • Peripheral blood smear (thick = sensitivity, thin = species identification)
  • RDT (Rapid Diagnostic Test) - HRP-2 antigen for P. falciparum
  • PCR (most sensitive)
Treatment:
  • Uncomplicated P. falciparum: Artemisinin-based Combination Therapy (ACT) - Artemether-lumefantrine
  • Severe malaria: IV Artesunate (first line, replaced quinine)
  • P. vivax/ovale (radical cure): Chloroquine + Primaquine (clears hypnozoites; check G6PD first!)
  • Prophylaxis: Doxycycline, Mefloquine, Atovaquone-proguanil (Malarone)

Leishmania

SpeciesDiseaseVectorDistribution
L. donovaniVisceral (Kala-azar)Sandfly (Phlebotomus)India, Africa
L. tropica, majorCutaneous (Oriental sore)SandflyMiddle East, Asia
L. braziliensisMucocutaneousSandfly (Lutzomyia)South America
Kala-azar features: Fever, massive splenomegaly, hepatomegaly, weight loss, hyperpigmentation (kala-azar = black fever), pancytopenia, hypergammaglobulinaemia, post-kala-azar dermal leishmaniasis (PKDL)
Lab: Bone marrow/spleen aspirate - LD bodies (amastigotes in macrophages) Treatment: Miltefosine (oral, first line in India), Liposomal Amphotericin B, Meglumine antimoniate

Trypanosomiasis

African (Sleeping sickness)

  • T. brucei gambiense (West Africa, chronic) + T. brucei rhodesiense (East Africa, acute)
  • Vector: Tsetse fly (Glossina)
  • Chancre at bite β†’ stage 1 (blood, lymph, winterbottom's sign = posterior cervical lymphadenopathy) β†’ stage 2 (CNS)
  • Treatment: Pentamidine/suramin (stage 1), Melarsoprol (stage 2)

American (Chagas disease)

  • T. cruzi
  • Vector: Triatomine bug (kissing bug/Reduviid bug), infects via faeces
  • Chagoma, RomaΓ±a's sign (periorbital oedema)
  • Chronic: Cardiomyopathy, megaoesophagus, megacolon
  • Treatment: Benznidazole or Nifurtimox (acute phase)

Intestinal Parasites (Rapid Fire)

ParasiteDiseaseKey Features
Entamoeba histolyticaAmoebic dysentery, liver abscessFlask-shaped ulcers, "anchovy sauce" pus, RBC in cysts, metronidazole treatment
Giardia lambliaGiardiasisSteatorrhoea, trophozoite = "falling leaf motility", cyst = 4 nuclei, duodenal aspirate
CryptosporidiumWatery diarrhoea in AIDSOocysts on modified ZN, self-limiting in immunocompetent, nitazoxanide
Ascaris lumbricoidesRoundworm, LΓΆffler's syndromeLargest intestinal nematode
HookwormIron deficiency anaemiaAncylostoma (buccal teeth), Necator (cutting plates)
StrongyloidesDiarrhoea, larva currens, hyperinfection in immunocompromisedFilariform larvae in stool, ivermectin treatment
Trichuris trichiuraWhipworm, rectal prolapse in childrenBarrel-shaped eggs
Enterobius vermicularisPinworm, perianal pruritisScotch tape test, paddlewheel eggs
Taenia soliumTaeniasis + cysticercosisPork tapeworm, cysticercosis β†’ neurocysticercosis
Taenia saginataTaeniasis onlyBeef tapeworm, no cysticercosis
EchinococcusHydatid cyst (liver, lung)Dog tapeworm, Casoni test, "daughter cysts", Albendazole + PAIR procedure

Tissue/Blood Parasites

ParasiteDiseaseVector/TransmissionKey Diagnostic
Wuchereria bancroftiLymphatic filariasis, elephantiasisCulex mosquitoNocturnal periodicity, microfilariae in blood at night
Brugia malayiLymphatic filariasisMansonia mosquito-
Loa loaLoiasis, Calabar swellingsChrysops (deer fly)Microfilariae in blood daytime
Onchocerca volvulusRiver blindnessSimulium (black fly)Microfilariae in skin snips
Dracunculus medinensisGuinea wormCyclops copepodWorm emerges from skin; DEET + filtering water
Toxoplasma gondiiToxoplasmosisCat faeces/raw meatCongenital (periventricular calcifications), AIDS (ring-enhancing lesions)
ToxocaraVisceral larva migransDog/cat faeces (eggs)Eosinophilia, retinal granuloma

SECTION 13: STERILISATION & DISINFECTION

Key Definitions

  • Sterilisation: Destruction of ALL microorganisms including spores
  • Disinfection: Destruction of most pathogens (not necessarily spores)
  • Antiseptic: Used on living tissues
  • Disinfectant: Used on inanimate objects
  • Bactericidal: Kills bacteria
  • Bacteriostatic: Inhibits growth

Methods

MethodTemp/DetailsUsed For
Autoclaving121Β°C, 15 psi, 15 minGold standard sterilisation, kills spores
Hot air oven160Β°C Γ— 1 hr or 180Β°C Γ— 30 minGlassware, oils, powders (NO steam)
Pasteurisation72Β°C Γ— 15 sec (HTST) or 63Β°C Γ— 30 min (Holder)Milk, kills non-sporing pathogens
Tyndallisation100Β°C Γ— 30 min on 3 consecutive daysKills spores by repeated steaming
IncinerationBurningInfected waste, carcasses
UV radiation260 nmAir disinfection, laminar flow cabinets, creates thymine dimers in DNA
Gamma irradiation2.5 MradDisposable syringes, sutures (cold sterilisation)
Ethylene oxide (EO)55Β°C, 4-8 hrsHeat-sensitive equipment (endoscopes, catheters)
Glutaraldehyde (2%)4-10 hrs for sterilisationHigh-level disinfection/sterilisation of endoscopes

SECTION 14: IMMUNOLOGY (Micro-related)

Complement System

Classical pathway: Activated by antigen-antibody complex (IgG, IgM) Lectin pathway: Activated by mannose-binding lectin (MBL) Alternative pathway: Activated by bacterial surfaces, LPS (spontaneous)
All converge at C3 β†’ C3 convertase β†’ C5 convertase β†’ MAC (Membrane Attack Complex) C5b-9
Functions:
  • C3b - Opsonisation (most important)
  • C3a, C5a - Anaphylatoxins (mast cell degranulation)
  • C5a - Chemotaxis (PMN recruitment), most potent
  • C5b-9 (MAC) - Lysis of Gram-negative bacteria
  • C1q - clearance of immune complexes
Terminal complement deficiency (C5-C9): Recurrent Neisseria infections

Hypersensitivity (Gell & Coombs)

TypeMechanismMediatorsExamples
Type I (Immediate)IgE, mast cells, basophilsHistamine, leukotrienesAnaphylaxis, asthma, urticaria, allergic rhinitis
Type II (Cytotoxic)IgG/IgM + complement or ADCCComplement, NK cellsHaemolytic anaemia, ITP, Goodpasture, ABO incompatibility
Type III (Immune complex)IgG/IgM complexes + complementC3a, C5a, neutrophilsSLE, PSGN, Arthus reaction, serum sickness
Type IV (Delayed/Cell-mediated)T cells (CD4 Th1, CD8)Lymphokines, macrophagesTuberculin test, contact dermatitis, graft rejection, sarcoidosis
Microbe-related hypersensitivity:
  • PSGN β†’ Type III (streptococcal antigen-antibody complexes)
  • Tuberculin test β†’ Type IV
  • Rheumatic fever β†’ Type II (molecular mimicry) + Type III

Immunoglobulins

IgKey Features
IgGMost abundant in serum, crosses placenta (only one), secondary response, 4 subclasses
IgMLargest, first produced (primary response), best complement activator (classical), pentamer
IgAMost abundant in secretions (secretory IgA = dimer + J chain + secretory component), protects mucosal surfaces
IgELowest serum concentration, binds mast cells/basophils, type I hypersensitivity, anti-parasitic
IgDB-cell surface receptor (with IgM), function largely unknown

SECTION 15: HIGH-YIELD ONE-LINERS (NEET PG Favourite Facts)

Cannot be cultured:
  • T. pallidum (dark-field microscopy)
  • M. leprae (armadillo footpad)
  • Rickettsia (cell culture only)
  • Chlamydia (cell culture only)
  • P. jirovecii (GMS stain)
Obligate intracellular:
  • Viruses (all), Rickettsia, Chlamydia, Coxiella, Mycobacterium leprae (facultative), Leishmania, Toxoplasma, Plasmodium
Capsulated bacteria (SHiNE SKiS): S. pneumoniae, H. influenzae, N. meningitidis, E. coli K1, Salmonella, Klebsiella, S. agalactiae
Oxidase positive: Neisseria, Pseudomonas, Vibrio, Campylobacter, Helicobacter, Brucella, Pasteurella Oxidase negative: Enterobacteriaceae (E. coli, Salmonella, Shigella, Klebsiella)
Urease positive: H. pylori, Proteus, Klebsiella, Cryptococcus, Ureaplasma
Catalase positive: Staphylococcus, most Gram-negatives Catalase negative: Streptococcus, Enterococcus (used to differentiate from Staph)
Coagulase positive: S. aureus only (among Staph)
CAMP test positive: S. agalactiae (Group B Strep)
Beta-haemolytic Streptococci: Group A (S. pyogenes), Group B (S. agalactiae), some Group C and G
Spore-forming bacteria: Bacillus (aerobic), Clostridium (anaerobic)
Zoonoses and their vectors:
DiseaseOrganismAnimal/Vector
PlagueY. pestisRat flea
Lyme diseaseB. burgdorferiIxodes tick
RMSFR. rickettsiiDermacentor tick
BrucellosisBrucella spp.Cattle/goat/sheep
Q feverCoxiella burnetiiInhalation of animal aerosols
LeptospirosisLeptospiraRat urine
AnthraxB. anthracisCattle/sheep spores
TularaemiaF. tularensisRabbit/tick
PsittacosisC. psittaciBirds (parrots)
HantavirusSin Nombre virusRodent aerosols
Most common causes - quick reference:
  • Most common bacterial meningitis (adults) β†’ S. pneumoniae
  • Most common bacterial meningitis (neonates) β†’ GBS (S. agalactiae) + E. coli K1
  • Most common meningitis (meningitis belt Africa) β†’ N. meningitidis
  • Most common UTI β†’ E. coli
  • Most common CAP β†’ S. pneumoniae
  • Most common food-borne diarrhoea (globally) β†’ Campylobacter jejuni
  • Most common nosocomial infection β†’ UTI (CAUTI)
  • Most common cause of osteomyelitis β†’ S. aureus
  • Most common organism in diabetic foot β†’ S. aureus (polymicrobial in chronic)
  • Most common cause of SBE β†’ Viridans streptococci
  • Most common cause of acute endocarditis β†’ S. aureus
  • Most common cause of prosthetic valve endocarditis (early, <60 days) β†’ S. epidermidis
  • Most common fungal infection in AIDS β†’ Candida (oral thrush earliest)
  • Most common cause of infectious blindness β†’ Trachoma (C. trachomatis)
  • Most common STI globally β†’ HPV
  • Most common STI in India β†’ Trichomonas vaginalis

That covers all of Microbiology for NEET PG - bacteriology, virology, mycology, parasitology, immunology, and sterilisation. Want me to run a targeted quiz on any specific section to test your retention? 🎯

Anesthesia revisi

πŸ’‰ Anesthesia Complete Revision

NEET PG Master Guide


SECTION 1: GENERAL PRINCIPLES

MAC (Minimum Alveolar Concentration)

Definition: The concentration of inhaled anaesthetic (in alveoli at 1 atm) that prevents movement in 50% of patients in response to a standard surgical stimulus (skin incision)
MAC values (must memorise):
AgentMAC (%)Key Property
Nitrous oxide (Nβ‚‚O)105%Only agent >100% (cannot achieve surgical anaesthesia alone)
Halothane0.75%Most potent, hepatotoxic
Isoflurane1.15%Respiratory depressant, coronary steal
Sevoflurane2.0%Smooth induction, paediatrics, compound A nephrotoxicity
Desflurane6.0%Fastest recovery, airway irritant (avoid induction), boils at room temp
Enflurane1.68%Convulsions (EEG spikes), avoid in epilepsy
Factors DECREASING MAC (drug/agent works at lower concentration):
  • Old age
  • Hypothermia
  • Hypothyroidism
  • Hypotension
  • Pregnancy
  • Opioids, benzodiazepines, alpha-2 agonists
  • Anaemia (severe)
  • Increased COβ‚‚
Factors INCREASING MAC (need more drug):
  • Children (peak at ~6 months)
  • Hyperthermia
  • Hyperthyroidism
  • Chronic alcohol use
  • Red hair (genetically higher MAC)
Meyer-Overton Rule: MAC correlates inversely with oil-water partition coefficient (lipid solubility). Higher lipid solubility β†’ lower MAC β†’ more potent.

Blood-Gas Partition Coefficient (Solubility)

Controls speed of induction and recovery
AgentBlood:Gas CoefficientSpeed
Desflurane0.42Fastest induction + recovery
Nβ‚‚O0.47Fast
Sevoflurane0.69Fast (good for paediatrics)
Isoflurane1.4Intermediate
Enflurane1.8Slower
Halothane2.4Slow
Ether (diethyl ether)12Slowest
Low blood-gas coefficient = gas poorly soluble in blood = stays in alveoli = fast equilibration = fast induction and fast recovery
Memory: "Desirable Fast Sevoflurane Iso Enf Halo Ether" = D F S I E H E (decreasing speed)

Second Gas Effect & Diffusion Hypoxia

Second gas effect: Nβ‚‚O, when absorbed rapidly, concentrates co-administered volatile agents (and Oβ‚‚) in alveoli β†’ faster induction with second gas
Diffusion hypoxia (Fink effect):
  • At end of Nβ‚‚O anaesthesia, Nβ‚‚O rapidly diffuses from blood into alveoli
  • Dilutes alveolar Oβ‚‚ and COβ‚‚
  • β†’ Hypoxia + hypoventilation
  • Prevention: Give 100% Oβ‚‚ for 5-10 minutes at end of anaesthesia

SECTION 2: INHALATIONAL AGENTS

Nitrous Oxide (Nβ‚‚O)

Properties:
  • Colourless, sweet smell, non-flammable (but supports combustion)
  • MAC = 105% (cannot produce anaesthesia alone at 1 atm)
  • Blood-gas coefficient 0.47 β†’ fast induction
  • Diffuses into air-containing cavities (30x more soluble than Nβ‚‚)
Contraindications due to cavity expansion:
  • Pneumothorax (expands)
  • Bowel obstruction (expands bowel)
  • Middle ear surgery (expands middle ear)
  • Air embolism (expands gas)
  • Pneumocephalus (after neurosurgery)
  • Retinal detachment surgery (SF6 gas in eye)
  • Tympanoplasty
Other properties:
  • Analgesic (strongest analgesic among volatile agents)
  • Entonox = 50% Nβ‚‚O + 50% Oβ‚‚ (obstetric analgesia, labour pain)
  • Inhibits methionine synthase (Vitamin B12-dependent enzyme) β†’ megaloblastic anaemia with prolonged use
  • "Second gas effect"

Halothane

Properties:
  • Sweetish, non-irritant, good for mask induction
  • MAC 0.75%, blood-gas 2.4 (slow induction)
  • Sensitises myocardium to catecholamines β†’ arrhythmias (avoid adrenaline with halothane)
  • Halothane hepatitis (type II - immune-mediated) - rare but fatal (~1:35,000)
    • More common with repeated exposure
    • Trifluoroacetyl chloride (metabolite) acts as hapten β†’ autoantibodies
  • Causes malignant hyperthermia (trigger agent)
  • Uterine relaxation (tocolytic) - avoid in obstetrics (PPH risk)

Sevoflurane

Advantages:
  • Non-pungent, non-irritant β†’ gold standard for gaseous induction in children
  • Fast (blood-gas 0.69)
  • Minimal cardiovascular effects
Disadvantages:
  • Compound A (degradation product in soda lime) β†’ nephrotoxicity (theoretical, high-flow anaesthesia recommended)
  • Fluoride ions released (renal concerns, but clinical nephrotoxicity rare)

Isoflurane

  • Pungent smell β†’ avoid for induction (use IV induction)
  • Most common volatile agent used
  • Causes coronary steal phenomenon (dilates normal coronaries, steals from diseased areas)
  • Potent respiratory depressant
  • Good muscle relaxation

Desflurane

  • Lowest blood-gas coefficient (0.42) after Nβ‚‚O
  • Fastest wake-up (ideal for outpatient/day surgery)
  • Highly pungent - CANNOT be used for induction (laryngospasm, bronchospasm)
  • Requires special heated vaporiser (boils at 23.5Β°C near room temp)
  • ↑ Heart rate and BP on rapid increase in concentration (sympathomimetic)
  • Minimal metabolism (least hepatotoxicity)

Ether (Historical but asked)

  • Blood-gas coefficient = 12 (slowest)
  • Excellent muscle relaxant (used to be sole agent)
  • Analgesia without muscle relaxation β†’ Stage 1 analgesia
  • Stages of anaesthesia described for ether (Guedel's stages)
  • Flammable, explosive
  • Safest agent - wide therapeutic index, cardiovascular stability
  • Still used in some resource-poor settings

SECTION 3: GUEDEL'S STAGES OF ANAESTHESIA

(Described for ether, but concept applies)
StageNameFeatures
Stage IAnalgesiaConscious, analgesic, amnesia starts
Stage IIExcitement/DeliriumUnconscious but excited, irregular breathing, vomiting risk, dangerous stage
Stage IIISurgical anaesthesiaRegular breathing, planes I-IV
Stage IVMedullary depressionRespiratory + cardiovascular collapse β†’ death
Stage III planes:
  • Plane 1: Eyeballs moving, some reflexes
  • Plane 2: Eyeballs fixed, loss of corneal reflex
  • Plane 3: Intercostal paralysis begins, ideal for most surgery
  • Plane 4: Complete intercostal paralysis, diaphragmatic only
Target for surgery: Stage III, Plane 2-3

SECTION 4: IV ANAESTHETIC AGENTS

Thiopentone (Thiopental)

  • Ultrashort-acting barbiturate (highly lipid soluble β†’ rapid brain uptake)
  • Onset 30 sec, duration 5-10 min (redistribution, NOT metabolism)
  • Gold standard for rapid sequence induction (RSI) historically
  • pH 10.5 (highly alkaline) - precipitates with acidic drugs (e.g., suxamethonium - never mix in same syringe)
  • Anticonvulsant (drug of choice for status epilepticus - IV)
  • ↓ ICP, ↓ cerebral Oβ‚‚ consumption β†’ used in raised ICP
  • NOT analgesic - anti-analgesic in subanaesthetic doses
Contraindications:
  • Porphyria (absolute - precipitates acute porphyric crisis)
  • Airways obstruction
  • Asthma (histamine release)
Complications:
  • Intra-arterial injection β†’ white precipitate β†’ intense vasospasm β†’ gangrene
    • Management: Papaverine (vasodilator) intra-arterially, heparin, sympathetic block

Propofol

  • Milky white emulsion (soybean oil, egg lecithin, glycerol)
  • Onset 30-40 sec, smooth, pleasant induction
  • Fastest recovery among IV agents (ideal for day-case surgery)
  • Context-sensitive half-life very low with infusion
  • Antiemetic properties (reduces PONV - post-operative nausea/vomiting)
  • ↓ ICP (used in neurosurgery TIVA)
PROPOFOL INFUSION SYNDROME:
  • Prolonged high-dose infusion (>4 mg/kg/hr for >48 hrs)
  • Features: Metabolic acidosis, rhabdomyolysis, cardiac failure, renal failure, lipidaemia
  • Most common in children and critically ill adults
  • Mechanism: Impaired mitochondrial electron transport chain
Other features:
  • Pain on injection (use large vein/lidocaine pretreatment)
  • No analgesic properties
  • Anti-epileptic in high doses, pro-convulsant in low doses
  • Contraindicated: Egg/soya allergy (relative), children <3 years for ICU sedation

Ketamine

  • Phencyclidine derivative
  • Dissociative anaesthesia - unique state (analgesia + amnesia + sedation, eyes open, purposeless movements)
  • Mechanism: NMDA receptor antagonist (non-competitive)
Advantages:
  • Potent analgesic (unique among induction agents)
  • Bronchodilator (increases catecholamines β†’ Ξ²β‚‚ stimulation) β†’ drug of choice in asthmatic patients
  • Maintains airway reflexes (protective reflexes maintained)
  • ↑ BP, ↑ HR, ↑ cardiac output (sympathomimetic) β†’ DOC in haemodynamically unstable/shocked patients
  • Can be given IM (useful in uncooperative children, field conditions)
Disadvantages:
  • ↑ ICP, ↑ IOP β†’ contraindicated in head injury, glaucoma, hypertensive patients
  • Emergence phenomena (hallucinations, delirium, nightmares) - on recovery
    • Prevented by benzodiazepines (midazolam) given before ketamine
  • Hypersalivation (give atropine premedication)
  • Not suitable for ophthalmic surgery (↑ IOP)

Etomidate

  • Imidazole derivative
  • Most cardiovascular stable induction agent β†’ DOC in cardiovascular disease, cardiogenic shock
  • Minimal effect on BP, HR, cardiac output
Disadvantages:
  • Adrenocortical suppression (inhibits 11Ξ²-hydroxylase β†’ ↓ cortisol production)
    • Even a single induction dose causes 4-8 hrs of adrenal suppression
    • AVOID in sepsis/critically ill (controversial)
  • Involuntary muscle movements (myoclonus)
  • Pain on injection
  • Nausea/vomiting

Midazolam

  • Benzodiazepine, water-soluble at acidic pH, lipid-soluble at body pH
  • GABA-A receptor agonist (increases Cl⁻ conductance)
  • Uses: Premedication, anxiolysis, sedation, conscious sedation, anticonvulsant
  • Anterograde amnesia (ideal for premedication)
  • Reversal: Flumazenil (competitive antagonist at BZD site of GABA-A receptor)
  • Safe, minimal cardiovascular effects

Dexmedetomidine

  • Selective Ξ±-2 agonist (8x more selective than clonidine)
  • Sedation without respiratory depression (unique!)
  • Analgesic, anxiolytic
  • Decreases anaesthetic/opioid requirements
  • Uses: ICU sedation (allows rousable sedation), awake fibreoptic intubation, MAC procedures
  • Causes: Bradycardia, hypotension (dose-dependent)

SECTION 5: NEUROMUSCULAR BLOCKING AGENTS (NMBAs)

Classification

TypeMechanismExamples
DepolarisingMimics ACh, persistent depolarisationSuxamethonium (succinylcholine) only
Non-depolarisingCompetitive antagonism at nAChRAtracurium, vecuronium, rocuronium, pancuronium, cisatracurium

Suxamethonium (Succinylcholine)

  • Only depolarising NMBA in clinical use
  • Fastest onset (60-90 sec), shortest duration (5-10 min)
  • Drug of choice for rapid sequence intubation (RSI) and emergency intubation
  • Hydrolysed by pseudocholinesterase (plasma cholinesterase)
Sequence of paralysis: Small muscles (eyelids, digits) β†’ Limb muscles β†’ Trunk β†’ Diaphragm β†’ (all paralysed)
Recovery: Reverse order (diaphragm first)
Fasciculations: Suxamethonium causes initial fasciculations (visible muscle twitching) before paralysis
  • Due to depolarisation of motor end-plate
  • Cause post-op myalgia (muscle pains)
  • Prevented by small dose of non-depolarising agent (pre-curarisation)
Adverse effects:
EffectDetails
Malignant hyperthermia (MH)Most important! Triggered by suxamethonium + volatile agents
HyperkalaemiaK⁺ released from muscle depolarisation - normally +0.5 mEq/L, DANGEROUS in burns, crush injuries, denervation
BradycardiaEspecially with 2nd dose (muscarinic effect), children
Raised IOPAvoid in open eye injury
Raised ICP
Raised intragastric pressureOffset by lower oesophageal sphincter contraction
Prolonged apnoeaPseudocholinesterase deficiency (genetic) - dibucaine number
Absolute contraindications:
  • Burns (>72 hours post-burn)
  • Crush injuries, rhabdomyolysis
  • Denervation injuries (paraplegia, spinal cord injury)
  • Hyperkalaemia
  • Personal/family history of malignant hyperthermia
  • Pseudocholinesterase deficiency
Dibucaine number:
  • Dibucaine inhibits normal pseudocholinesterase by 80% (dibucaine number = 80)
  • Atypical pseudocholinesterase inhibited only 20% (dibucaine number = 20)
  • Low dibucaine number = atypical enzyme = prolonged suxamethonium action

Non-Depolarising NMBAs

Phase II (Dual) block:
  • Prolonged/repeated suxamethonium doses
  • Block character changes from depolarising to non-depolarising (reversible with neostigmine)

Atracurium

  • Intermediate duration
  • Hofmann elimination (spontaneous degradation at body pH/temp) - not dependent on liver/kidney
  • DOC in hepatic + renal failure
  • Releases histamine (avoid in asthmatics/allergy-prone)
  • Laudanosine (metabolite) - CNS excitatory, seizures (at high doses)

Cisatracurium

  • Isomer of atracurium
  • Same Hofmann elimination
  • Less histamine release than atracurium
  • Better choice in ICU

Vecuronium

  • Intermediate duration, steroid-based
  • Minimal cardiovascular effects (no histamine)
  • Hepatically metabolised (avoid in liver disease)

Rocuronium

  • Fastest onset among non-depolarising agents (90 sec at high dose)
  • Can be used instead of suxamethonium for RSI (at 1.2 mg/kg)
  • Reversed by Sugammadex (selective relaxant binding agent)
  • Minimal cardiovascular effects

Pancuronium

  • Long-acting
  • ↑ HR, ↑ BP (vagolytic + sympathomimetic) - useful in bradycardia but problem in hypertension/CAD
  • Renal elimination (avoid in renal failure)

Mivacurium

  • Shortest-acting non-depolarising agent
  • Hydrolysed by pseudocholinesterase (like suxamethonium)
  • Releases histamine

Reversal of NMBAs

Anticholinesterases (reverse non-depolarising)

  • Neostigmine (0.05 mg/kg) - most commonly used
  • Mechanism: Inhibits acetylcholinesterase β†’ ↑ ACh at NMJ β†’ competes with non-depolarising agent
Muscarinic side effects of neostigmine:
  • Bradycardia, increased secretions, bronchospasm, increased GI motility
  • Must give with atropine or glycopyrrolate (antimuscarinic)

Sugammadex

  • Modified Ξ³-cyclodextrin - encapsulates rocuronium/vecuronium
  • Reverses even profound (deep) neuromuscular block
  • Works for rocuronium and vecuronium only (not suxamethonium, atracurium)
  • Fastest reversal (deep block reversed within 3 minutes)
  • Dose: 2 mg/kg (moderate block), 4 mg/kg (deep), 16 mg/kg (immediate after suxamethonium-like dose of rocuronium)

SECTION 6: LOCAL ANAESTHETICS

Classification

ClassExamplesKey Feature
Amides (contain -NH-CO-)Lidocaine, Bupivacaine, Ropivacaine, Mepivacaine, PrilocaineHepatic metabolism
Esters (contain -COO-)Cocaine, Procaine, Tetracaine, Benzocaine, ChloroprocainePlasma esterase hydrolysis, PABA metabolite
Memory: Amides have 2 i's in name (lidocaIne, bupIvacaIne) - mnemonic: "I-I" for Amide

Mechanism

  • Block voltage-gated Na⁺ channels from inside the cell
  • Bind to open/inactivated channels (use-dependent/frequency-dependent block)
  • Preferentially block small, myelinated fibres first
Order of block (smallest to largest): Pain (AΞ΄) β†’ Temperature β†’ Touch β†’ Pressure β†’ Motor (last)
  • Small unmyelinated (C fibres - pain/temperature) blocked first
  • Large myelinated (AΞ± - motor) blocked last

Individual Agents

Lidocaine (Lignocaine)

  • Most widely used
  • Amide, intermediate duration (1-2 hrs)
  • Maximum dose: Plain = 3 mg/kg; With adrenaline = 7 mg/kg
  • IV lidocaine = antiarrhythmic (Class IB)
  • Topical on trachea before intubation (attenuates pressor response)

Bupivacaine

  • Long-acting (4-8 hrs) - ideal for postop analgesia
  • Maximum dose: 2 mg/kg (plain); 2.5 mg/kg (with adrenaline)
  • Cardiotoxic (blocks cardiac Na⁺ and K⁺ channels, causes refractory VF)
  • Treatment of bupivacaine cardiotoxicity: 20% Intralipid (lipid emulsion rescue)
  • 0.5% heavy bupivacaine used for spinal anaesthesia (hyperbaric = with glucose)

Ropivacaine

  • Newer amide, long-acting
  • Less cardiotoxic than bupivacaine (S-enantiomer, larger molecule, slower cardiac binding)
  • Motor-sparing at lower concentrations (good for labour epidurals)

Cocaine

  • Only local anaesthetic that is vasoconstrictor (inhibits noradrenaline reuptake)
  • Used in ENT (nasal surgery) - combines anaesthesia + vasoconstriction
  • All other LAs are vasodilators (except cocaine)

Prilocaine

  • Causes methaemoglobinaemia (metabolite o-toluidine oxidises Hb to MetHb)
  • Treatment: Methylene blue IV
  • EMLA cream = Eutectic Mixture of LAs = Prilocaine + Lidocaine (topical for PICC, children)

Adrenaline with Local Anaesthetics

Benefits: Prolongs action (vasoconstriction reduces absorption), reduces toxicity, reduces bleeding
Contraindicated with adrenaline:
  • Ring block (digits/penis/ear/nose) - end arteries, risk of ischaemia/gangrene
  • IV regional anaesthesia (Bier's block)
  • Cocaine (already vasoconstrictive)

Local Anaesthetic Toxicity

CNS (first affected, lower threshold):
  • Mild: Perioral tingling, tinnitus, metallic taste, lightheadedness
  • Moderate: Slurred speech, diplopia, muscle twitching
  • Severe: Convulsions β†’ CNS depression β†’ Coma
CVS (higher dose needed):
  • Cardiac arrhythmias, bradycardia
  • Bupivacaine β†’ refractory VF (most cardiotoxic)
Treatment:
  1. Stop injection, 100% Oβ‚‚
  2. Treat convulsions: Midazolam or Thiopentone
  3. Cardiac arrest: CPR
  4. 20% Intralipid (lipid emulsion) - for severe CVS toxicity (especially bupivacaine)

SECTION 7: REGIONAL ANAESTHESIA

Spinal Anaesthesia (Subarachnoid Block)

Needle: Quincke (cutting, 22-25G), Whitacre/Sprotte (pencil point, less PDPH) Level: Usually L3-L4 or L4-L5 interspace (below L2 where spinal cord ends = conus medullaris) Spinal cord ends: L1-L2 in adults, L3 in neonates
Drug: 0.5% heavy bupivacaine (hyperbaric - with 8% dextrose)
  • Heavy solution settles in dependent areas β†’ position determines block level
Advantages: Complete block, less drug used, good muscle relaxation, awake patient
Contraindications:
  • Absolute: Patient refusal, infection at site, coagulopathy, raised ICP, hypovolaemia (relative)
  • Relative: Systemic sepsis, pre-existing neurological disease, severe aortic stenosis
Complications:
ComplicationDetails
Post-dural puncture headache (PDPH)Postural (worse sitting/standing), bilateral frontal/occipital; due to CSF leak; treat with bed rest/fluids, epidural blood patch (gold standard)
HypotensionMost common; due to sympathetic block; treat with IV fluids + vasopressors (ephedrine - preferred in obstetrics)
High/Total spinalBlock of cervical segments β†’ apnoea, cardiovascular collapse; emergency airway management
Urinary retentionSacral root block
BradycardiaCardiac accelerator fibers (T1-T4) blocked
Cauda equina syndromeRare, large volume/concentration injection

Epidural Anaesthesia

Space: Epidural space (between ligamentum flavum and dura mater)
  • Contains: Epidural fat, venous plexus (Batson's plexus), nerve roots
  • Negative pressure in epidural space (hanging drop technique or loss of resistance technique)
Advantages over spinal:
  • Can be topped up (catheter) β†’ prolonged/continuous anaesthesia
  • Can control level more precisely
  • Less hypotension than spinal (slower sympathetic block)
Test dose: 3 mL 1.5% lidocaine + 1:200,000 adrenaline
  • Intravascular injection β†’ tachycardia (adrenaline)
  • Intrathecal injection β†’ rapid dense block
Uses:
  • Labour analgesia (most common use)
  • Thoracic/abdominal surgery (combined spinal-epidural)
  • Post-operative analgesia
  • Cancer pain management

Brachial Plexus Blocks

ApproachLevel BlockedBest ForSpared
InterscaleneC5, C6, C7Shoulder, proximal armUlnar nerve (C8, T1 often spared)
SupraclavicularTrunksEntire arm below shoulderMost complete block
InfraclavicularCordsArm, forearm-
AxillaryPeripheral nervesForearm, handMusculocutaneous nerve (not in axillary sheath)
Interscalene block complications:
  • Phrenic nerve palsy (ipsilateral hemidiaphragm) - always occurs β†’ avoid in respiratory compromise
  • Recurrent laryngeal nerve palsy
  • Stellate ganglion block β†’ Horner's syndrome
  • Vertebral artery injection

SECTION 8: MALIGNANT HYPERTHERMIA

Triggers

  • All volatile anaesthetic agents (halothane, isoflurane, sevoflurane, desflurane)
  • Suxamethonium
Safe agents: Propofol, barbiturates, benzodiazepines, Nβ‚‚O, local anaesthetics, non-depolarising NMBAs

Pathophysiology

  • Autosomal dominant mutation in ryanodine receptor (RYR1) gene on chromosome 19
  • Uncontrolled Ca²⁺ release from sarcoplasmic reticulum
  • Massive muscle contraction β†’ heat production

Clinical Features

  • ↑ End-tidal COβ‚‚ (FIRST sign) - most sensitive early indicator
  • Hyperthermia (may rise 1Β°C every 5 minutes)
  • Muscle rigidity (masseter spasm first - "jaws of steel")
  • Tachycardia, arrhythmias
  • Dark urine (myoglobinuria)
  • Metabolic and respiratory acidosis
  • DIC

Treatment

  1. Stop all triggers immediately (turn off volatile agents)
  2. Dantrolene (2.5 mg/kg IV bolus, repeat up to 10 mg/kg) - specific treatment
    • Mechanism: Blocks RYR1 receptor β†’ prevents Ca²⁺ release from SR
  3. Active cooling (ice packs, cold IV fluids)
  4. Correct acidosis, hyperkalaemia
  5. Maintain urine output (rhabdomyolysis β†’ renal failure)
  6. ICU admission
Dantrolene = only drug; also used in neuroleptic malignant syndrome (NMS)

MH vs NMS

FeatureMalignant HyperthermiaNMS
TriggerVolatile anaesthetics, suxamethoniumAntipsychotics (haloperidol, chlorpromazine)
MechanismRyanodine receptor, ↑ Ca²⁺Dopamine D2 receptor blockade
Rigidity"Lead-pipe" rigidity"Lead-pipe" rigidity
OnsetMinutes (intraop)Days to weeks
TreatmentDantrolene + stop triggerBromocriptine + dantrolene

SECTION 9: OPIOIDS

Classification

TypeExamples
NaturalMorphine, Codeine
Semi-syntheticHeroin, Oxycodone, Hydromorphone, Buprenorphine
SyntheticFentanyl, Remifentanil, Alfentanil, Methadone, Tramadol, Pethidine

Receptors

ReceptorEffects
ΞΌ (mu)Analgesia (supraspinal + spinal), euphoria, respiratory depression, reduced GI motility, miosis, physical dependence
ΞΊ (kappa)Analgesia (spinal), sedation, miosis, dysphoria
Ξ΄ (delta)Analgesia, antidepressant

Key Opioids

Morphine

  • Gold standard opioid
  • Active metabolite: Morphine-6-glucuronide (M6G) - potent, accumulates in renal failure β†’ prolonged sedation
  • Histamine release β†’ hypotension, bronchospasm
  • Avoid in renal failure (M6G accumulation)

Fentanyl

  • 100x more potent than morphine
  • Highly lipid-soluble β†’ rapid onset, short duration (redistribution)
  • No histamine release β†’ preferred in asthmatics and haemodynamically unstable
  • Fentanyl patches (transdermal) for chronic pain

Remifentanil

  • Ultra-short-acting opioid
  • Hydrolysed by non-specific esterases in plasma and tissues (NOT pseudocholinesterase)
  • Context-insensitive - duration same regardless of infusion length
  • Recovery in minutes even after prolonged infusion β†’ ideal for TIVA
  • No histamine release
  • Caution: acute tolerance and hyperalgesia after prolonged infusion

Tramadol

  • Weak ΞΌ agonist + inhibits reuptake of serotonin and noradrenaline
  • "Atypical opioid"
  • Less respiratory depression than traditional opioids
  • Lowers seizure threshold
  • Can cause serotonin syndrome (especially with SSRIs/MAOIs)
  • Metabolised by CYP2D6 to O-desmethyltramadol (active)

Pethidine (Meperidine)

  • Metabolite: Norpethidine - CNS excitatory, causes seizures (accumulates in renal failure)
  • Anticholinergic effects (dry mouth, tachycardia)
  • Serotonin syndrome risk with MAOIs (absolute contraindication)
  • Historically used in shivering (reduces shivering threshold)
  • Least likely to cause spasm of sphincter of Oddi (relatively) among opioids

Buprenorphine

  • Partial ΞΌ agonist + ΞΊ antagonist
  • Ceiling effect on respiratory depression (safer in overdose)
  • High receptor affinity β†’ difficult to reverse with naloxone
  • Used in opioid dependence (sublingual)

Methadone

  • Long-acting (24-36 hrs), oral bioavailability ~80%
  • NMDA antagonist (helps neuropathic pain)
  • Used for opioid substitution therapy
  • QTc prolongation risk

Opioid Adverse Effects

EffectDetails
Respiratory depressionDecreased sensitivity to COβ‚‚, ↓ RR before ↓ tidal volume
Miosis (pinpoint pupils)ΞΌ receptor on Edinger-Westphal nucleus; does NOT develop tolerance
ConstipationΞΌ receptors in GI tract; does NOT develop tolerance
Nausea/vomitingChemoreceptor trigger zone (CTZ) stimulation
Urinary retentionDetrusor muscle, urethral sphincter spasm
PruritusHistamine release (morphine) + central mechanism
BradycardiaVagal stimulation
Euphoria/DependenceΞΌ receptor in limbic system

Opioid Reversal - Naloxone

  • Pure ΞΌ, ΞΊ, Ξ΄ antagonist (competitive)
  • IV, IM, intranasal
  • Duration 30-45 min (shorter than most opioids β†’ may need repeat dosing or infusion)
  • Can precipitate acute withdrawal in dependent patients
  • "Naloxone challenge" - diagnosis of opioid dependence

SECTION 10: AIRWAY MANAGEMENT

ASA Difficult Airway Algorithm

Predicted difficult airway assessment:
  • LEMON law:
    • Look externally (facial hair, obesity, anatomy)
    • Evaluate (3-3-2 rule: 3 finger mouth opening, 3 finger thyromental, 2 finger hyoid-thyroid)
    • Mallampati
    • Obstruction/Obesity
    • Neck mobility

Mallampati Classification

ClassViewPrediction
ISoft palate, fauces, uvula, pillarsEasy intubation
IISoft palate, fauces, part of uvulaEasy
IIISoft palate, base of uvulaDifficult
IVHard palate onlyVery difficult

Laryngoscopy & Intubation

Cormack-Lehane grading (view at laryngoscopy):
  • Grade I: Full glottis visible
  • Grade II: Arytenoids visible
  • Grade III: Epiglottis only visible
  • Grade IV: Nothing visible
Endotracheal tube sizes:
  • Adult male: 8.0-9.0 mm ID
  • Adult female: 7.0-8.0 mm ID
  • Children: (Age/4) + 4 for uncuffed; (Age/4) + 3.5 for cuffed
Confirmation of ETT placement:
  1. Capnography (ETCOβ‚‚) - gold standard
  2. Bilateral breath sounds
  3. Chest rise
  4. CXR (tube tip 2-4 cm above carina)

Rapid Sequence Intubation (RSI)

Indication: Full stomach (risk of aspiration) Sequence:
  1. Preoxygenation (3 min tidal breathing or 8 vital capacity breaths)
  2. Cricoid pressure (Sellick's manoeuvre) - compresses oesophagus against C6 vertebra, prevents regurgitation
  3. Induction agent (Thiopentone or Propofol)
  4. Suxamethonium 1.5 mg/kg (or Rocuronium 1.2 mg/kg if MH risk)
  5. Intubation (no bag-mask ventilation before intubation)
  6. Release cricoid after cuff inflated and placement confirmed

Laryngeal Mask Airway (LMA)

  • Supraglottic airway device (sits above larynx, no cuff in trachea)
  • Does NOT protect against aspiration (unlike ETT)
  • Size 3 = small adult (females), Size 4 = average adult, Size 5 = large adult
Contraindications:
  • Full stomach/aspiration risk
  • Upper airway obstruction
  • Need for high airway pressures (morbid obesity, poor compliance)
i-gel = Newer supraglottic device, no inflatable cuff (gel-based)

SECTION 11: MONITORING

ASA Standard Monitoring (Mandatory for all GA)

  1. Pulse oximetry (SpOβ‚‚) - continuous
  2. NIBP - every 5 minutes minimum
  3. ECG - continuous
  4. Capnography (ETCOβ‚‚) - mandatory during intubation
  5. Temperature - for cases >30 minutes
  6. Inspired Oβ‚‚ concentration (FiOβ‚‚)

Capnography (ETCOβ‚‚)

Normal ETCOβ‚‚ = 35-45 mmHg (slightly less than PaCOβ‚‚)
ETCOβ‚‚ changes:
FindingCauses
↑ ETCOβ‚‚Hypoventilation, ↑ COβ‚‚ production (MH, fever), rebreathing
↓ ETCOβ‚‚Hyperventilation, ↓ cardiac output, pulmonary embolism, oesophageal intubation (sudden drop to zero)
Absent ETCOβ‚‚Oesophageal intubation, cardiac arrest, apnoea
Sudden drop + no waveformOesophageal intubation, disconnection

Pulse Oximetry

  • Measures SpOβ‚‚ (oxygen saturation of Hb) using Beer-Lambert law
  • Measures ratio of absorbance at 660 nm (red, deoxyHb) and 940 nm (infrared, oxyHb)
Causes of false readings:
  • COHb (carbon monoxide) - falsely HIGH SpOβ‚‚ (CO-Hb absorbs like OxyHb)
  • MetHb - SpOβ‚‚ reads ~85% regardless of actual saturation
  • Nail polish (dark colours), motion artefact, hypoperfusion

Bispectral Index (BIS)

  • Processed EEG monitor for depth of anaesthesia
  • Scale 0-100: 40-60 = adequate anaesthesia; >80 = awake/light sedation; <40 = deep (burst suppression)
  • Reduces awareness under anaesthesia

SECTION 12: PREOPERATIVE ASSESSMENT

ASA Physical Status Classification

ClassDescriptionExample
INormal healthy patientNo disease
IIMild systemic diseaseControlled DM, mild asthma
IIISevere systemic disease (not incapacitating)Uncontrolled DM, COPD
IVIncapacitating systemic disease, life-threateningUnstable angina, severe ESRD
VNot expected to survive without surgeryRuptured AAA
VIBrain-dead, organ donation-
E suffixEmergency surgeryASA III-E

Preoperative Fasting (Nil By Mouth - NBM)

"2-4-6-8 rule":
  • 2 hours - Clear fluids (water, tea, coffee without milk)
  • 4 hours - Breast milk
  • 6 hours - Light meal (toast), formula milk, non-human milk
  • 8 hours - Full meal

Premedication

Aims:
  • Anxiolysis (benzodiazepines)
  • Analgesia (opioids, NSAIDs)
  • Antisialagogue - dry mouth (atropine, glycopyrrolate)
  • Antiemetic (ondansetron, metoclopramide)
  • Antacid (ranitidine, proton pump inhibitors)
  • Aspiration prophylaxis (sodium citrate)

SECTION 13: SPINAL/EPIDURAL COMPARISON

FeatureSpinalEpidural
SiteSubarachnoid spaceEpidural space
Drug volumeSmall (2-3 mL)Large (10-20 mL)
OnsetFast (2-5 min)Slow (15-20 min)
Drug doseLowHigh
ToxicityLess (low dose)More (high dose)
Repeat dosingCannot (single shot)Yes (via catheter)
PDPHMore commonLess (dura not punctured)
HypotensionMore common + severeLess severe
Height controlPosition + baricityVolume + concentration

SECTION 14: COMPLICATIONS OF ANAESTHESIA

Awareness Under Anaesthesia

  • Incidence: ~1-2 per 1000 GA cases
  • Risk factors: RSI, cardiopulmonary bypass, trauma/obstetrics, muscle relaxants without adequate hypnotics
  • Prevention: BIS monitoring, adequate TIVA dosing, volatile agent monitoring (MAC)

Post-Operative Nausea and Vomiting (PONV)

Apfel Score (risk factors):
  1. Female sex
  2. Non-smoker
  3. History of PONV/motion sickness
  4. Post-op opioids
Score 0 = 10% risk, Score 4 = 79% risk
Treatment/Prophylaxis:
  • 5-HT₃ antagonists (Ondansetron) - first line
  • Dexamethasone (8 mg IV)
  • Droperidol (small doses)
  • Propofol TIVA (reduces PONV vs volatile agents)
  • Transdermal scopolamine
  • Total IV anaesthesia (TIVA) significantly reduces PONV

SECTION 15: HIGH-YIELD RAPID FIRE

"Single best drug" for each scenario:
SituationDrug of Choice
RSI (rapid sequence intubation)Suxamethonium + Thiopentone
Reversal of non-depolarising blockNeostigmine + Atropine
Reversal of rocuronium/vecuroniumSugammadex
Malignant hyperthermiaDantrolene
Local anaesthetic toxicity20% Intralipid
Opioid overdoseNaloxone
Benzodiazepine overdoseFlumazenil
Asthmatic patient (induction)Ketamine
Haemodynamically unstable (induction)Ketamine or Etomidate
Cardiovascular disease (induction)Etomidate
Day-case/outpatient (IV induction)Propofol
Paediatric gaseous inductionSevoflurane
Fastest recovery volatile agentDesflurane
Hepatic/renal failure (NMBA)Atracurium or Cisatracurium
Porphyria (AVOID)Thiopentone (barbiturates)
Open eye injury (AVOID suxamethonium)Rocuronium + Sugammadex
Raised ICP (AVOID)Ketamine, Suxamethonium

Most common complications:
  • Most common complication of spinal = Hypotension
  • Most common cause of failed intubation = Obesity
  • Most common cause of PONV = Opioids + volatile agents + female sex
  • Most common nerve injury in lithotomy position = Common peroneal nerve
  • Most common nerve injury in prone position = Brachial plexus

Specific drugs and their reversal:
  • Opioids β†’ Naloxone
  • Benzodiazepines β†’ Flumazenil
  • Non-depolarising NMBAs β†’ Neostigmine (+ atropine)
  • Rocuronium/Vecuronium β†’ Sugammadex (also works against neostigmine failure)
  • Heparin β†’ Protamine
  • Warfarin β†’ Vitamin K / FFP / PCC

That's the complete Anesthesia revision for NEET PG! All the high-yield topics from MAC values to malignant hyperthermia, local anaesthetics to opioids, airway management to monitoring.
Want a quick 10-question anesthesia quiz to test retention before your GT? 🎯

Ortho rapid revisio

Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.
This is a shared conversation. Sign in to Orris to start your own chat.